<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="gefs" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">gefs</book-part-id>
      <title-group>
        <title>
<italic toggle="yes">SCN1A</italic>-Related Seizure Disorders</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Miller</surname>
            <given-names>Ian O</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Director, Clinical Neuroinformatics<break/>Miami Children's Hospital<break/>Miami, Florida</aff>
          <email>ian.miller@mchdocs.com</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sotero de Menezes</surname>
            <given-names>Marcio A</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Director of Pediatric Epilepsy/Neurology and Genetic Epilepsy Clinic<break/>Pediatric Neuroscience Center<break/>Swedish Neuroscience Institute<break/>Clinical Associate Professor in Neurology<break/>University of Washington<break/>Seattle Children's Hospital<break/>Seattle, Washington</aff>
          <email>marcio.soterodemenezes@swedish.org</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date iso-8601-date="2007-11-29" date-type="created">
          <day>29</day>
          <month>11</month>
          <year>2007</year>
        </date>
        <date iso-8601-date="2014-05-15" date-type="updated">
          <day>15</day>
          <month>5</month>
          <year>2014</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="samd9l-ap" document-type="chapter"><italic toggle="yes">SAMD9L</italic>-Related Ataxia-Pancytopenia Syndrome</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="scn8a-ee" document-type="chapter"><italic toggle="yes">SCN8A</italic>-Related Epilepsy with Encephalopathy</related-object>
      <abstract id="gefs.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p><italic toggle="yes">SCN1A</italic>-related seizure disorders encompass a spectrum that ranges from simple febrile seizures (FS) and generalized epilepsy with febrile seizures plus (GEFS+) at the mild end to Dravet syndrome and intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC) at the severe end. Phenotypes with intractable seizures including Dravet syndrome (also known as severe myoclonic epilepsy in infancy [SMEI] or polymorphic myoclonic epilepsy in infancy [PMEI]) are usually associated with progressive dementia. Less commonly observed phenotypes include myoclonic-astatic epilepsy (MAE or Doose syndrome), Lennox-Gastaut syndrome (LGS), infantile spasms, and vaccine-related encephalopathy and seizures. The phenotype of <italic toggle="yes">SCN1A</italic>-related seizure disorders can vary even within the same family.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of <italic toggle="yes">SCN1A</italic>-related seizure disorders relies on detection of a heterozygous pathogenic variant in <italic toggle="yes">SCN1A</italic>.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations</italic>: Antiepileptic drugs (AEDs) include benzodiazepines (diazepam and clonazepam), stiripentol (used in Europe; not currently FDA approved for use in the US), topiramate, and valproic acid. Clobazam can be used for the treatment of seizures in Lennox-Gastaus syndrome. Phenobarbital is effective but poorly tolerated because of its effects on cognition. Use of the ketogenic diet to decrease seizure frequency has been beneficial in some affected individuals.</p>
          <p><italic toggle="yes">Prevention of secondary complications</italic>: Use of protective helmets by individuals with atonic seizures or myoclonic-astatic epilepsy.</p>
          <p><italic toggle="yes">Surveillance</italic>: Serial neuropsychological evaluation for neurologic, cognitive, and behavioral deterioration; EEG monitoring for new or different seizure types.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid</italic>: AEDs: carbamazepine, lamotrigine, and vigabatrin, which can induce or increase myoclonic seizures; phenytoin, which can induce choreoathetosis. Activities in which a sudden loss of consciousness could lead to injury or death (e.g., bathing, swimming, driving, or working/playing at heights).</p>
          <p><italic toggle="yes">Pregnancy management</italic>: Pregnant women should receive counseling regarding the risks and benefits of the use of antiepileptic drugs during pregnancy; the advantages and disadvantages of increasing maternal periconceptional folic acid supplementation to 4000 &#x000b5;g daily; the effects of pregnancy on anticonvulsant metabolism; and the effect of pregnancy on maternal seizure control.</p>
          <p><italic toggle="yes">Other</italic>: The AEDs clobazam and stiripentol, used in treatment of SMEI, are not FDA-approved for this use in the US. Sleep deprivation and illness can exacerbate seizures. Persons with epilepsy should be made aware of motor vehicle driving laws.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p><italic toggle="yes">SCN1A</italic>-related seizure disorders are inherited in an autosomal dominant manner. A proband with an <italic toggle="yes">SCN1A</italic>-related seizure disorder may have an inherited or <italic toggle="yes">de novo</italic> pathogenic variant. The proportion of cases caused by <italic toggle="yes">de novo</italic> pathogenic variants varies by phenotype: the percentage of probands with an <italic toggle="yes">SCN1A</italic>-related seizure disorder and an affected parent decreases as the severity of the phenotype in the proband increases; thus, most <italic toggle="yes">SCN1A</italic>-related SMEI and ICE-GTC are the result of <italic toggle="yes">de novo</italic> mutation. Each child of an individual with an <italic toggle="yes">SCN1A</italic>-related seizure disorder has a 50% chance of inheriting the pathogenic variant; however, the risk of developing seizures is less than 100% because of reduced penetrance. Prenatal diagnosis for pregnancies at increased risk is possible if the pathogenic variant in the family is known.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="gefs.GeneReview_Scope">
        <title><italic toggle="yes">GeneReview</italic> Scope</title>
        <table-wrap id="gefs.Tc" position="anchor" orientation="portrait">
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_gefs.Tc_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1"><italic toggle="yes">SCN1A</italic>-Related Seizure Disorders: Included Phenotypes&#x000a0;<sup>1</sup></th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_gefs.Tc_1_1_1_1" valign="middle" align="left" rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>Generalized epilepsy with febrile seizures plus</p>
                    </list-item>
                    <list-item>
                      <p>Intractable childhood epilepsy with generalized tonic-clonic seizures</p>
                    </list-item>
                    <list-item>
                      <p>Intractable infantile partial seizures</p>
                    </list-item>
                    <list-item>
                      <p>Myoclonic-astatic epilepsy</p>
                    </list-item>
                    <list-item>
                      <p>Severe myoclonic epilepsy in infancy</p>
                    </list-item>
                    <list-item>
                      <p>Simple febrile seizures</p>
                    </list-item>
                  </list>
                </td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>For synonyms and outdated names see <xref ref-type="sec" rid="gefs.Nomenclature">Nomenclature</xref>.</p>
            </fn>
            <fn id="gefs.TF.c.1">
              <label>1. </label>
              <p>For other genetic causes of these phenotypes see <xref ref-type="sec" rid="gefs.Differential_Diagnosis">Differential Diagnosis</xref>.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="gefs.Diagnosis">
        <title>Diagnosis</title>
        <p><italic toggle="yes">SCN1A</italic>-related seizure disorders encompass a spectrum of phenotypes that ranges from mild to severe. Because clinical findings alone cannot establish the diagnosis, detection of a heterozygous pathogenic <italic toggle="yes">SCN1A</italic> variant is necessary. Identification of an <italic toggle="yes">SCN1A</italic> pathogenic variant may also have implications for medical management of the affected individual&#x02019;s seizure disorder (see <xref ref-type="sec" rid="gefs.Treatment_of_Manifestations">Treatment of Manifestations</xref> and <xref ref-type="sec" rid="gefs.AgentsCircumstances_to_Avoid">Agents/Circumstances to Avoid</xref>).</p>
        <p><bold>The phenotypes seen in <italic toggle="yes">SCN1A</italic>-related seizure disorders</bold> include the following*:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Febrile seizures (FS),</bold> which may or may not have features suggestive of an <italic toggle="yes">SCN1A</italic>-related condition</p>
          </list-item>
          <list-item>
            <p>
              <bold>Generalized epilepsy with febrile seizures plus (GEFS+)</bold>
            </p>
          </list-item>
          <list-item>
            <p><bold>Dravet syndrome,</bold> also known as <bold>severe myoclonic epilepsy in infancy (SMEI)</bold> or <bold>polymorphic myoclonic epilepsy in infancy (PMEI)</bold>Note: The term "Dravet syndrome" is preferred because the myoclonic seizures implied by the descriptive name(s) can be absent in children whose seizures are otherwise similar.</p>
          </list-item>
          <list-item>
            <p>
              <bold>Severe myoclonic epilepsy, borderline (SMEB)</bold>
            </p>
          </list-item>
          <list-item>
            <p><bold>Intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC),</bold> which does not represent an epilepsy defined by ILAE, and is most similar to late-onset Dravet syndrome in the ILAE classification system Note: This classification is widely used in the <italic toggle="yes">SCN1A</italic> literature and is thus included for completeness.</p>
          </list-item>
          <list-item>
            <p><bold>Infantile partial seizures with variable foci,</bold> also referred to as <bold>migrating partial seizures of infancy</bold>, <bold>cryptogenic focal epilepsy</bold>, or <bold>severe infantile multifocal epilepsy</bold> per <xref ref-type="bibr" rid="gefs.REF.harkin.2007.843">Harkin et al [2007]</xref></p>
          </list-item>
        </list>
        <p>*Note: Terms used in the literature to describe the phenotypes sometimes differ from the standard epilepsy syndrome terminology as defined by the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ilae-epilepsy.org/">International League Against Epilepsy</ext-link> (ILAE).</p>
        <p>
          <bold>Less commonly associated phenotypes</bold>
        </p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Myoclonic-astatic epilepsy (MAE, Doose syndrome),</bold> initially defined conceptually as a group of individuals with a genetic predisposition to generalized epilepsies. In the ILAE classification system it is a superset including Dravet syndrome, benign myoclonic epilepsy, and childhood-onset epilepsies with primarily generalized seizures.</p>
          </list-item>
          <list-item>
            <p><bold>Lennox-Gastaut syndrome (LGS),</bold> associated with slow-spike wave on EEG, generalized seizures, and intellectual disability. <xref ref-type="bibr" rid="gefs.REF.selmer.2009.555">Selmer et al [2009]</xref> reported finding one adult with LGS in a cohort of 22 who had an <italic toggle="yes">SCN1A</italic> pathogenic variant.</p>
          </list-item>
          <list-item>
            <p>
              <bold>Infantile spasms</bold>
            </p>
          </list-item>
          <list-item>
            <p>
              <bold>Vaccine-related encephalopathy and seizures</bold>
            </p>
          </list-item>
        </list>
        <p><bold>The clinical suspicion of <italic toggle="yes">SCN1A</italic>-related seizure disorders</bold> is complicated by the following three issues:</p>
        <list list-type="bullet">
          <list-item>
            <p>The phenotypes cover a broad spectrum of severity, even within the same family.</p>
          </list-item>
          <list-item>
            <p>The epilepsy phenotypes are incompletely specific (i.e., they are seen in other conditions as well).</p>
          </list-item>
          <list-item>
            <p>Some epilepsy phenotypes refer to features observed in the family, rather than in a particular individual in the family.</p>
          </list-item>
        </list>
        <p><bold>Familial features that have some specificity for <italic toggle="yes">SCN1A</italic>-related seizure disorders</bold> include the following.</p>
        <list list-type="bullet">
          <list-item>
            <p>One or more family members with epilepsy, especially of more than one type</p>
          </list-item>
          <list-item>
            <p>Febrile seizures:</p>
            <list list-type="bullet">
              <list-item>
                <p>Before age one year [<xref ref-type="bibr" rid="gefs.REF.bonanni.2004.149">Bonanni et al 2004</xref>]</p>
              </list-item>
              <list-item>
                <p>After age six years [<xref ref-type="bibr" rid="gefs.REF.scheffer.1997.479">Scheffer &#x00026; Berkovic 1997</xref>]</p>
              </list-item>
              <list-item>
                <p>With unusual severity (including status epilepticus) [<xref ref-type="bibr" rid="gefs.REF.baulac.1999.1078">Baulac et al 1999</xref>]</p>
              </list-item>
              <list-item>
                <p>That precede unprovoked (i.e., afebrile) seizures (which may be generalized tonic-clonic, myoclonic, myoclonic-astatic, or absence) [<xref ref-type="bibr" rid="gefs.REF.scheffer.1997.479">Scheffer &#x00026; Berkovic 1997</xref>]</p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p>A history of seizures following vaccination</p>
          </list-item>
          <list-item>
            <p>Hemiconvulsive seizures</p>
          </list-item>
          <list-item>
            <p>Seizures triggered by environmental stimuli, including heat, temperature changes, bright lights, or busy, noisy environments</p>
          </list-item>
        </list>
        <p>Note: Because the suggestive features may occur in some members of the family and not others, a complete family history must be taken.</p>
        <p><bold>The diagnosis of an <italic toggle="yes">SCN1A-</italic>related seizure disorder</bold> requires detection of a heterozygous pathogenic <italic toggle="yes">SCN1A</italic> variant. See <xref ref-type="table" rid="gefs.T.summary_of_molecular_genetic_test">Table 1</xref>.</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>One approach</bold> is molecular genetic testing of <italic toggle="yes">SCN1A</italic>. Sequence analysis of the entire coding region of <italic toggle="yes">SCN1A</italic> is performed first. If a pathogenic variant is not identified, deletion/duplication analysis is performed.</p>
          </list-item>
          <list-item>
            <p><bold>An alternative approach</bold> is use of a multi-gene panel that includes <italic toggle="yes">SCN1A</italic> and other genes of interest (see <xref ref-type="sec" rid="gefs.Differential_Diagnosis">Differential Diagnosis</xref>). Note: The genes included and the methods used in multi-gene panels vary by laboratory and over time.</p>
          </list-item>
        </list>
        <table-wrap id="gefs.T.summary_of_molecular_genetic_test" position="anchor" orientation="portrait">
          <label>Table 1. </label>
          <caption>
            <p>Summary of Molecular Genetic Testing Used in <italic toggle="yes">SCN1A</italic>-Related Seizure Disorders</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_gefs.T.summary_of_molecular_genetic_test_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                <th id="hd_h_gefs.T.summary_of_molecular_genetic_test_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                <th id="hd_h_gefs.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with a Pathogenic Variant Detectable by This Method</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_gefs.T.summary_of_molecular_genetic_test_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                  <italic toggle="yes">SCN1A</italic>
                </td>
                <td headers="hd_h_gefs.T.summary_of_molecular_genetic_test_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>2</sup></td>
                <td headers="hd_h_gefs.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">73%-92%&#x000a0;<sup>3</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_gefs.T.summary_of_molecular_genetic_test_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>4</sup></td>
                <td headers="hd_h_gefs.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">8%-27%&#x000a0;<sup>5,&#x000a0;6, 7,&#x000a0;8</sup></td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="gefs.TF.1.1">
              <label>1. </label>
              <p>See <related-object source-id="gene" document-id="gefs" object-id="gefs.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein. See <xref ref-type="sec" rid="gefs.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants.</p>
            </fn>
            <fn id="gefs.TF.1.2">
              <label>2. </label>
              <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
            </fn>
            <fn id="gefs.TF.1.3">
              <label>3. </label>
              <p>Estimated value based on subtracting experimental values of deletion frequencies of 8%-27% from 100% (see footnote 5).</p>
            </fn>
            <fn id="gefs.TF.1.4">
              <label>4. </label>
              <p>Testing that identifies exon or whole-gene deletions/duplications not readily detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA. Included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
            </fn>
            <fn id="gefs.TF.1.5">
              <label>5. </label>
              <p>Using a variety of methods to identify deletions encompassing the <italic toggle="yes">SCN1A</italic> locus in individuals with SMEI who did not have an <italic toggle="yes">SCN1A</italic> pathogenic variant identified on sequence analysis, <xref ref-type="bibr" rid="gefs.REF.madia.2006.1230">Madia et al [2006]</xref> found deletions in three of 39 (8%), <xref ref-type="bibr" rid="gefs.REF.mulley.2006.1094">Mulley et al [2006]</xref> found deletions in two of 13 (15%), and <xref ref-type="bibr" rid="gefs.REF.suls.2006.914">Suls et al [2006]</xref> found deletions in three of 11 (27%). In these three studies a total of eight of 63 (12%) individuals with SMEI who did not have a sequence variant identified on sequence analysis had an identifiable <italic toggle="yes">SCN1A</italic> deletion.</p>
            </fn>
            <fn id="gefs.TF.1.6">
              <label>6. </label>
              <p><xref ref-type="bibr" rid="gefs.REF.marini.2009.1670">Marini et al [2009]</xref> found that 12.5% of individuals with Dravet syndrome who did not have a pathogenic variant identified on sequence analysis had copy number variations that were detectable by MLPA.</p>
            </fn>
            <fn id="gefs.TF.1.7">
              <label>7. </label>
              <p>It is not known if the percent of exon and whole-gene deletions is the same for the other phenotypes in the spectrum of <italic toggle="yes">SCN1A</italic>-related seizure disorders.</p>
            </fn>
            <fn id="gefs.TF.1.8">
              <label>8. </label>
              <p>A contiguous gene deletion syndrome of severe epilepsy, intellectual disability, and dysmorphic features that includes the genes <italic toggle="yes">SCN1A</italic> and <italic toggle="yes">SCN2A</italic> at chromosomal locus 2q23-q24. One affected individual has been described [<xref ref-type="bibr" rid="gefs.REF.pereira.2004.191">Pereira et al 2004</xref>].</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>
          <bold>Secondary or modulatory genes in individuals with <italic toggle="yes">SCN1A</italic> pathogenic variants</bold>
        </p>
        <list list-type="bullet">
          <list-item>
            <p><bold><italic toggle="yes">SCN9A.</italic></bold> Pathogenic variants in <italic toggle="yes">SCN9A</italic> are thought to have a role in modulating disease resulting from <italic toggle="yes">SCN1A</italic> variants; in some cases isolated
<italic toggle="yes">SCN9A</italic> variants (without <italic toggle="yes">SCN1A</italic> alterations) have been associated with Dravet Syndrome [<xref ref-type="bibr" rid="gefs.REF.singh.2009.e1000649">Singh et al 2009</xref>, <xref ref-type="bibr" rid="gefs.REF.mulley.2013.e122">Mulley et al 2013</xref>] (see <xref ref-type="sec" rid="gefs.Differential_Diagnosis">Differential Diagnosis</xref>).</p>
          </list-item>
          <list-item>
            <p><bold><italic toggle="yes">CACNB4</italic>.</bold> An individual with a missense variant (Arg468Gln) of <italic toggle="yes">CACNB4</italic> in addition to a <italic toggle="yes">de novo</italic>
<italic toggle="yes">SCN1A</italic> nonsense variant (Arg568Ter) showed a Dravet phenotype. The phenotype of Dravet syndrome was thought to be due at least in part to the augmentation of the excitatory neurotransmitter release mediated by the increased Ca(v)2.1 currents [<xref ref-type="bibr" rid="gefs.REF.ohmori.2008b.349">Ohmori et al 2008b</xref>].</p>
          </list-item>
          <list-item>
            <p><bold><italic toggle="yes">CACNA1A</italic>.</bold> A larger study of 48 people with Dravet syndrome with <italic toggle="yes">SCN1A</italic> pathogenic variants found that 21/48 had alterations of <italic toggle="yes">CACNA1A</italic> that appeared to be common variants (polymorphisms). The authors then compared the clinical features of affected individuals with documented <italic toggle="yes">SCN1A</italic> pathogenic variants who had a <italic toggle="yes">CACNA1A</italic> polymorphism to those affected individuals who did not have a <italic toggle="yes">CACNA1A</italic> polymorphism. Forty individuals in the study had documented <italic toggle="yes">SCN1A</italic> pathogenic variants and Dravet syndrome; of these 40 individuals, the clinical features of 20 individuals with a <italic toggle="yes">CACNA1A</italic> polymorphism were compared to the phenotypes of 20 without a <italic toggle="yes">CACNA1A</italic> polymorphism [<xref ref-type="bibr" rid="gefs.REF.ohmori.2013.209">Ohmori et al 2013</xref>]. Affected individuals with a <italic toggle="yes">CACNA1A</italic> polymorphism had earlier onset of seizures, more frequent prolonged seizures before age one year, and more frequent absence seizures [<xref ref-type="bibr" rid="gefs.REF.ohmori.2013.209">Ohmori et al 2013</xref>].</p>
          </list-item>
          <list-item>
            <p><bold><italic toggle="yes">POLG.</italic></bold>
<xref ref-type="bibr" rid="gefs.REF.gaily.2013.1577">Gaily et al [2013]</xref> reported two individuals with the combination of a heterozygous <italic toggle="yes">POLG</italic> variant (p.Trp748Ser or p.Gly517Val) and a heterozygous <italic toggle="yes">SCN1A</italic> pathogenic variant. The affected individuals had prolonged seizures with acute encephalopathy and persistent neurologic deficits postictally. The observation requires further confirmation because heterozygous <italic toggle="yes">POLG</italic> variants have not generally been associated with seizures and deterioration, which are more typically present in those with compound heterozygous or homozygous <italic toggle="yes">POLG</italic> pathogenic variants.</p>
          </list-item>
        </list>
        <p>Note: The role of the so-called modulatory genes must be interpreted with caution given the phenotypic variability in Dravet syndrome associated with a given pathogenic variant. That said, the phenotypic variability in Dravet syndrome will be only explained when a comprehensive list of possible modifier factors has been compiled.</p>
      </sec>
      <sec id="gefs.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="gefs.Clinical_Description">
          <title>Clinical Description</title>
          <p>The natural history of <italic toggle="yes">SCN1A</italic>-related seizure disorders is strongly influenced by seizure phenotype, which can range from simple febrile seizures (FS) and generalized epilepsy with febrile seizures plus (GEFS+) at the mild end to severe myoclonic epilepsy of infancy (SMEI) and intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC) at the severe end [<xref ref-type="bibr" rid="gefs.REF.kimura.2005.424">Kimura et al 2005</xref>, <xref ref-type="bibr" rid="gefs.REF.mantegazza.2005.18177">Mantegazza et al 2005</xref>, <xref ref-type="bibr" rid="gefs.REF.fujiwara.2006.s223">Fujiwara 2006</xref>, <xref ref-type="bibr" rid="gefs.REF.gennaro.2006.489">Gennaro et al 2006</xref>].</p>
          <p>The phenotype varies even among family members with the same pathogenic variant. <xref ref-type="fig" rid="gefs.F1">Figure 1</xref> shows a pedigree that demonstrates variable expressivity. As a result of this variable expressivity, long-term prognosis is difficult to predict.</p>
          <p>Features associated with poor cognitive outcome include early myoclonic and absence seizures [<xref ref-type="bibr" rid="gefs.REF.ragona.2011.386">Ragona et al 2011</xref>].</p>
          <p>Seizures tend to lessen in severity after puberty; however, they rarely resolve completely. Only approximately 16% of individuals with Dravet syndrome had complete resolution of their seizures, meaning that anticonvulsant treatment is usually lifelong. Complete resolution tended to occur in individuals with less severe seizures earlier in life. <xref ref-type="bibr" rid="gefs.REF.akiyama.2010.1043">Akiyama et al [2010]</xref> found that resolution of seizures correlated with having less than three lifetime episodes of convulsive status epilepticus.</p>
          <p>Phenotypes with intractable seizures (e.g., Dravet syndrome) usually cause epileptic encephalopathy, a form of progressive dementia. The root cause of the encephalopathy is unknown: the effects of seizures, the most obvious explanation, cannot be separated from the effects of medication or the effects of mutation of <italic toggle="yes">SCN1A</italic> on cognition [<xref ref-type="bibr" rid="gefs.REF.riva.2009.2339">Riva et al 2009</xref>].</p>
          <p>In addition to having seizures in response to strong environmental stimuli, individuals with mutation of <italic toggle="yes">SCN1A</italic> often have an ADHD-like phenotype characterized by impulsivity, inattentiveness, and distractibility. Possibly related to the inability of the GABA system to &#x0201c;filter out&#x0201d; unimportant sensory input, these symptoms tend to be fairly unresponsive to conventional stimulant medications.</p>
          <p>Individuals with severe epilepsy phenotypes often develop the locomotor findings of postural change (flexion at the hips, knees, and trunk, giving a &#x0201c;hunched over&#x0201d; appearance) and ataxia. In spite of the gait being commonly described as &#x0201c;ataxic&#x0201d;, affected individuals seem to be quite a bit more skilled than one would expect from how crouched they appear. The gait changes tend to be more prevalent in older children. In one study these changes were absent before age 5 years, but present in 5/10 children ages 6-12 years and in 8/9 children age 13 years or older [<xref ref-type="bibr" rid="gefs.REF.rodda.2012.873">Rodda et al 2012</xref>]. In one cohort, 5/10 adults with Dravet syndrome had crouched gait [<xref ref-type="bibr" rid="gefs.REF.rilstone.2012.1421">Rilstone et al 2012</xref>]. The patterns that worsened with increasing age were: decreased passive knee extension and hip extension; increased external tibial torsion; and pes planovalgus [<xref ref-type="bibr" rid="gefs.REF.rodda.2012.873">Rodda et al 2012</xref>]. The hip internal rotation did not show age-related changes. The gait changes usually begin in childhood, but often develop after the onset of epilepsy. The degree of ataxia in affected individuals is greater than would be expected by the use of anticonvulsant medications alone.</p>
          <p>The phenotypes in <italic toggle="yes">SCN1A</italic>-related seizure disorders, summarized in <xref ref-type="table" rid="gefs.T.distribution_of_seizure_phenotype">Table 2</xref>, include the following:</p>
          <p><bold>Febrile seizures (FS).</bold> These childhood seizures occur only in association with fever. The epidemiologic definition requires the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Onset on or after age six months</p>
            </list-item>
            <list-item>
              <p>Resolution by age five years</p>
            </list-item>
            <list-item>
              <p>Fever higher than 38&#x000b0; C (without other evidence of CNS infection)</p>
            </list-item>
            <list-item>
              <p>No other identifiable cause</p>
            </list-item>
          </list>
          <p>Febrile seizures are divided into simple febrile seizures and complex febrile seizures. Febrile seizures are considered complex if any of the following is present:</p>
          <list list-type="bullet">
            <list-item>
              <p>Duration greater than 15 minutes</p>
            </list-item>
            <list-item>
              <p>Occurrence of more than one seizure within 24 hours</p>
            </list-item>
            <list-item>
              <p>Presence of any partial (focal) features during the seizure</p>
            </list-item>
          </list>
          <p><bold>Febrile seizures plus (FS+).</bold> This subset of febrile seizures (simple or complex) has any of the following features:</p>
          <list list-type="bullet">
            <list-item>
              <p>Onset before age one year</p>
            </list-item>
            <list-item>
              <p>Persistence beyond age six years</p>
            </list-item>
            <list-item>
              <p>Unusual severity (including status epilepticus)</p>
            </list-item>
            <list-item>
              <p>Occurrence of unprovoked (i.e., afebrile) seizures of any kind</p>
            </list-item>
          </list>
          <p><bold>Generalized epilepsy.</bold> This phenotype is otherwise indistinguishable from idiopathic generalized epilepsy with onset in childhood or adolescence. Generalized epilepsies caused by mutation of <italic toggle="yes">SCN1A</italic> are most often tonic, clonic, tonic-clonic, myoclonic, or absence.</p>
          <p><bold>Generalized epilepsy with febrile seizures plus (GEFS+).</bold>This term refers to the findings in a family rather than an individual [<xref ref-type="bibr" rid="gefs.REF.arzimanoglou.2004">Arzimanoglou et al 2004</xref>].</p>
          <p>In a family with GEFS+, epilepsy with variable expressivity and incomplete penetrance is inherited in an autosomal dominant manner. Although the complete range of associated phenotypes can be seen within any family, the seizure phenotypes tend toward the mild end of the spectrum [<xref ref-type="bibr" rid="gefs.REF.scheffer.1997.479">Scheffer &#x00026; Berkovic 1997</xref>] because the more severe seizure types have a reproductive disadvantage and, thus, are less likely to be familial [<xref ref-type="bibr" rid="gefs.REF.claes.2001.1327">Claes et al 2001</xref>].</p>
          <p>Affected individuals within a family with GEFS+ often have febrile seizures (or FS+) in early childhood, followed by occasional tonic, clonic, myoclonic, or absence seizures which respond to medication and remit by late childhood or early adolescence. The proportion of children with GEFS+ whose first seizure occurs in the context of immunization appears to be greater than the proportion of children with febrile seizures unrelated to FS+ and GEFS+.</p>
          <p><bold>Dravet syndrome.</bold> This phenotype is defined as seizures with onset during the first year of life (usually around age six months; in some cases before age three months) that do not remit, and usually evolve to include myoclonic seizures.</p>
          <list list-type="bullet">
            <list-item>
              <p>Early seizures are often prolonged febrile seizures. Seizures can sometimes be provoked by modest hyperthermia (e.g., a hot bath, physical exertion).</p>
            </list-item>
            <list-item>
              <p>Any seizure type is possible; generalized tonic-clonic, myoclonic, and hemiconvulsive seizures are most common.</p>
            </list-item>
            <list-item>
              <p>Myoclonic seizures tend to appear later in the course, often coinciding with the appearance of cognitive dysfunction, ataxia, and psychomotor regression.</p>
            </list-item>
            <list-item>
              <p>Status epilepticus is common, and pharmacologic management is difficult.</p>
            </list-item>
            <list-item>
              <p>The initial EEGs are often normal, but over time epileptiform activity appears. Patterns can include generalized spike and wave discharges, multiple spike and wave (also referred to as polyspike and wave) discharges, and multifocal spikes.</p>
            </list-item>
          </list>
          <p><bold>Severe myoclonic epilepsy, borderline (SMEB).</bold>This description is sometimes used for children who have some but not all of the features of SMEI [<xref ref-type="bibr" rid="gefs.REF.fukuma.2004.140">Fukuma et al 2004</xref>].</p>
          <p><bold>Intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC).</bold> This phenotype is defined as generalized seizures including absence seizures and generalized tonic-clonic seizures with onset in infancy or childhood. However, partial seizures can occur in up to 13% of affected individuals [<xref ref-type="bibr" rid="gefs.REF.bonanni.2004.149">Bonanni et al 2004</xref>]. Localized epilepsy, either alternating hemiconvulsive or complex partial seizures, may also be seen. Children with frequent generalized tonic-clonic seizures often develop cognitive impairment. The distinction between ICE-GTC and Dravet syndrome is not clear, and the former is not included in the ILAE classification system.</p>
          <p><bold>Infantile partial seizures with variable foci</bold>. This phenotype is defined as focal seizures beginning in infancy with multiple independent zones of seizure onset involving both hemispheres. Multifocal partial seizures are often the first manifestation; however, in some children the first manifestation is febrile seizures. Severity varies and pharmacoresistance is common, but not absolute. Myoclonic seizures are rare but may be precipitated by administration of medications that inactivate the sodium channel, including phenytoin, carbamazepine, or lamotrigine. Cognitive deterioration may occur, especially when seizure control is incomplete. Electroencephalography shows multifocal independent spikes; generalized spike and wave discharges may be seen.</p>
          <table-wrap id="gefs.T.distribution_of_seizure_phenotype" position="anchor" orientation="portrait">
            <label>Table 2. </label>
            <caption>
              <p>Distribution of Seizure Phenotypes in <italic toggle="yes">SCN1A</italic>-Related Seizure Disorders</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_gefs.T.distribution_of_seizure_phenotype_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Disorder</th>
                  <th id="hd_h_gefs.T.distribution_of_seizure_phenotype_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Distribution</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_gefs.T.distribution_of_seizure_phenotype_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Simple febrile seizures (FS)</td>
                  <td headers="hd_h_gefs.T.distribution_of_seizure_phenotype_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Unknown</td>
                </tr>
                <tr>
                  <td headers="hd_h_gefs.T.distribution_of_seizure_phenotype_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Febrile seizures plus (FS+)</td>
                  <td headers="hd_h_gefs.T.distribution_of_seizure_phenotype_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Unknown</td>
                </tr>
                <tr>
                  <td headers="hd_h_gefs.T.distribution_of_seizure_phenotype_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Generalized epilepsy with febrile seizures plus (GEFS+)</td>
                  <td headers="hd_h_gefs.T.distribution_of_seizure_phenotype_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">5%-10%&#x000a0;<sup>1</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_gefs.T.distribution_of_seizure_phenotype_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Severe myoclonic epilepsy in infancy (SMEI)</td>
                  <td headers="hd_h_gefs.T.distribution_of_seizure_phenotype_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">33%-90%&#x000a0;<sup>2</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_gefs.T.distribution_of_seizure_phenotype_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC)</td>
                  <td headers="hd_h_gefs.T.distribution_of_seizure_phenotype_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">70%&#x000a0;<sup>3</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="gefs.TF.2.1">
                <label>1. </label>
                <p>
                  <xref ref-type="bibr" rid="gefs.REF.marini.2007.1678">Marini et al [2007]</xref>
                </p>
              </fn>
              <fn id="gefs.TF.2.2">
                <label>2.&#x000a0;</label>
                <p>
                  <xref ref-type="bibr" rid="gefs.REF.mulley.2005.535">Mulley et al [2005]</xref>
                </p>
              </fn>
              <fn id="gefs.TF.2.3">
                <label>3.&#x000a0;</label>
                <p>
                  <xref ref-type="bibr" rid="gefs.REF.fujiwara.2003.531">Fujiwara et al [2003]</xref>
                </p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p>The features and course for the less common phenotypes associated with mutation of <italic toggle="yes">SCN1A</italic> include the following:</p>
          <p><bold>Myoclonic-astatic epilepsy (MAE, also called Doose syndrome).</bold>This phenotype is defined as the combination of myoclonic, atonic, and atypical absence seizures. Onset is usually after age two years (range: 7 months - 8 years).</p>
          <p>Although isolated myoclonic seizures as well as tonic seizures can occur, they are not characteristic of this syndrome (which distinguishes them from Lennox-Gastaut syndrome). Development prior to seizure onset is often normal. The course can range from spontaneous seizure resolution without cognitive impairment to intractable seizures with severe intellectual disability [<xref ref-type="bibr" rid="gefs.REF.arzimanoglou.2004">Arzimanoglou et al 2004</xref>].</p>
          <p><xref ref-type="bibr" rid="gefs.REF.ebach.2005.210">Ebach et al [2005]</xref> compared two cohorts in order to determine if the MAE phenotype was more specific for the presence of an <italic toggle="yes">SCN1A</italic> pathogenic variant than the severe idiopathic generalized epilepsy of infancy (SIGEI) phenotype. They found one pathogenic variant in 20 children with MAE and two pathogenic variants in 18 children with SIGEI; the small sample size precluded a statistically significant result.</p>
          <p><bold>Lennox-Gastaut syndrome (LGS).</bold> This phenotype is defined as slow spike-waves on EEG, developmental delay, and multiple types of generalized seizures (particularly atypical absence, tonic, and atonic seizures). LGS usually begins during childhood (ages 2-14 years). Any type of seizure can be seen in this syndrome; status epilepticus is common [<xref ref-type="bibr" rid="gefs.REF.arzimanoglou.2004">Arzimanoglou et al 2004</xref>]. Only a minority of persons with the LGS phenotype have an <italic toggle="yes">SCN1A</italic> pathogenic variant, usually in the context of a family in which Dravet syndrome occurs [<xref ref-type="bibr" rid="gefs.REF.singh.2001.837">Singh et al 2001</xref>]. This subset remains poorly characterized. It is unclear whether <italic toggle="yes">SCN1A</italic>-associated LGS differs phenotypically from LGS of other etiologies.</p>
          <p><bold>Infantile spasms.</bold> This phenotype is defined as clustered seizures that show brief (&#x0003c;1 second) axial contractions associated with a slow-wave transient on EEG, often followed by generalized attenuation of the background. Both findings may be intermixed with fast activity. The resting EEG (between seizures) shows high-voltage slowing and a multifocal spike pattern known as hypsarrhythmia [<xref ref-type="bibr" rid="gefs.REF.arzimanoglou.2004">Arzimanoglou et al 2004</xref>]. Association of an <italic toggle="yes">SCN1A</italic> pathogenic missense variant with infantile spasms has been reported once [<xref ref-type="bibr" rid="gefs.REF.wallace.2003.765">Wallace et al 2003</xref>]. The single case represents fewer than 1% of reported cases, although publication bias makes it difficult to estimate the actual proportion.</p>
          <p><bold>Vaccine-related encephalopathy and seizures.</bold> This phenotype is defined as sudden onset of seizures and encephalopathy in infants 48 hours after immunization. <xref ref-type="bibr" rid="gefs.REF.berkovic.2006.488">Berkovic et al [2006]</xref> identified an <italic toggle="yes">SCN1A</italic> pathogenic variant in 11/14 children diagnosed with post-vaccine encephalopathy. <xref ref-type="bibr" rid="gefs.REF.trobaumann.2011.175">Tro-Baumann et al [2011]</xref> reported that 19 of 70 individuals with an <italic toggle="yes">SCN1A</italic> pathogenic variant and the Dravet phenotype had a history of seizures following vaccination.</p>
          <p>Brain MRI is most often normal early in the course of the disease; however, it often evolves to show cortical atrophy, cerebellar atrophy, white matter hyperintensity, ventricular enlargement, hippocampal sclerosis, or cortical dysplasia [<xref ref-type="bibr" rid="gefs.REF.striano.2007.1092">Striano et al 2007</xref>]. Individuals with a more severe phenotype early in life often have more atrophic changes seen on MRI later in life.</p>
        </sec>
        <sec id="gefs.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p><xref ref-type="bibr" rid="gefs.REF.mulley.2005.535">Mulley et al [2005]</xref> found that most <italic toggle="yes">SCN1A</italic> pathogenic variants cluster in the C-terminus and in the pore loops connecting S5 and S6 especially in the first three domains of the protein (<xref ref-type="fig" rid="gefs.F2">Figure 2</xref>).</p>
          <p>Pathogenic nonsense variants and missense variants in the voltage sensor or pore region often lead to a more severe phenotype [<xref ref-type="bibr" rid="gefs.REF.zuberi.2011.594">Zuberi et al 2011</xref>]; a truncation variant, however, does not necessarily result in a severe phenotype [<xref ref-type="bibr" rid="gefs.REF.suls.2010.72">Suls et al 2010</xref>, <xref ref-type="bibr" rid="gefs.REF.yu.2010.443">Yu et al 2010</xref>].</p>
          <p>Affected individuals with missense variants in the pore-forming region and truncations in the SCN1A protein are more prone to have gait changes [<xref ref-type="bibr" rid="gefs.REF.kanai.2004.329">Kanai et al 2004</xref>, <xref ref-type="bibr" rid="gefs.REF.rilstone.2012.1421">Rilstone et al 2012</xref>]. These changes may be due to a direct effect of the <italic toggle="yes">SCN1A</italic> pathogenic variant in the cerebellar Purkinje cells [<xref ref-type="bibr" rid="gefs.REF.catterall.2010.1849">Catterall et al 2010</xref>].</p>
          <p>An estimated 5% of individuals with molecularly confirmed SMEI have a familial missense <italic toggle="yes">SCN1A</italic> variant that is associated with a milder phenotype (i.e., GEFS+) in other family members [<xref ref-type="bibr" rid="gefs.REF.mulley.2005.535">Mulley et al 2005</xref>].</p>
        </sec>
        <sec id="gefs.Nomenclature">
          <title>Nomenclature</title>
          <p>Generalized epilepsy with febrile seizures plus has been referred to as GEFS+ type 2.</p>
          <p>Intractable infantile partial seizures has been referred to as ICEGTC.</p>
        </sec>
        <sec id="gefs.Penetrance">
          <title>Penetrance</title>
          <p><italic toggle="yes">SCN1A</italic>-related seizure disorders show incomplete penetrance and variable expressivity.</p>
          <p>Penetrance varies by phenotype. For example, <xref ref-type="bibr" rid="gefs.REF.bonanni.2004.149">Bonanni et al [2004]</xref> estimated the penetrance to be 70% for the GEFS+ phenotype, whereas <xref ref-type="bibr" rid="gefs.REF.mantegazza.2005.18177">Mantegazza et al [2005]</xref> reported the penetrance to be 90% for the familial simple febrile seizure phenotype.</p>
        </sec>
        <sec id="gefs.Anticipation">
          <title>Anticipation</title>
          <p>Anticipation is not observed in <italic toggle="yes">SCN1A</italic>-related seizure disorders.</p>
        </sec>
        <sec id="gefs.Prevalence">
          <title>Prevalence</title>
          <p>The prevalence of <italic toggle="yes">SCN1A</italic>-related seizure disorders is unknown.</p>
        </sec>
      </sec>
      <sec id="gefs.Genetically_Related_Allelic_Disorde">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>Other phenotypes associated with pathogenic variants in <italic toggle="yes">SCN1A</italic>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Panayiotopolous syndrome [<xref ref-type="bibr" rid="gefs.REF.grosso.2007.609">Grosso et al 2007</xref>]</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="fhm" document-type="chapter">Familial hemiplegic migraine</related-object> [<xref ref-type="bibr" rid="gefs.REF.dichgans.2005.371">Dichgans et al 2005</xref>]</p>
          </list-item>
          <list-item>
            <p>Familial autism [<xref ref-type="bibr" rid="gefs.REF.weiss.2003.186">Weiss et al 2003</xref>]</p>
          </list-item>
          <list-item>
            <p>Rasmussen encephalitis associated with the pathogenic variant p.Arg1575Cys [<xref ref-type="bibr" rid="gefs.REF.ohmori.2008a.521">Ohmori et al 2008a</xref>]</p>
          </list-item>
        </list>
      </sec>
      <sec id="gefs.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The phenotypes typically seen with mutation of <italic toggle="yes">SCN1A</italic> are neither necessary nor sufficient to diagnose an <italic toggle="yes">SCN1A</italic>-related seizure disorder. Other conditions (including those caused by mutation of other genes) may be associated with the same phenotypes.</p>
        <p>It is most important to distinguish <italic toggle="yes">SCN1A</italic>-related seizure disorders from potentially treatable conditions, including the following [<xref ref-type="bibr" rid="gefs.REF.arzimanoglou.2004">Arzimanoglou et al 2004</xref>, <xref ref-type="bibr" rid="gefs.REF.roger.2006">Roger et al 2006</xref>]:</p>
        <list list-type="bullet">
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="pds" document-type="chapter">Pyridoxine-dependent seizures</related-object> and B<sub>6</sub>-related epilepsies</p>
          </list-item>
          <list-item>
            <p>"Folinic acid-responsive" seizures, a rare cause of epilepsy that improves with daily folinic acid administration</p>
          </list-item>
          <list-item>
            <p>Inborn errors of metabolism, including mitochondrial dysfunction, which may be diagnosed by the presence of abnormal serum concentrations of lactate, ketones, ammonia, amino acids, and/or abnormal concentrations of urine organic acids (see <related-object link-type="booklink" source-id="gene" document-id="mt-overview" document-type="chapter">Mitochondrial Diseases Overview</related-object>)</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="biotin" document-type="chapter">Biotinidase deficiency</related-object>, which is usually identified during newborn screening</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="glut1" document-type="chapter">Glucose transporter type 1 deficiency</related-object>, which is diagnosed by low CSF glucose concentrations, and responds to the ketogenic diet</p>
          </list-item>
          <list-item>
            <p>Hepatic porphyrias, which usually demonstrate photosensitive porphyrins in the urine and reduced monopyrrole porphobilinogen (PBG) deaminase in red cells (See <related-object link-type="booklink" source-id="gene" document-id="aip" document-type="chapter">Acute Intermittent Porphyria</related-object>, <related-object link-type="booklink" source-id="gene" document-id="porphyria-ct" document-type="chapter">Porphyria Cutanea Tarda</related-object>, <related-object link-type="booklink" source-id="gene" document-id="hcp" document-type="chapter">Hepatic Coproporphyria</related-object>, and <related-object link-type="booklink" source-id="gene" document-id="porphyria-var" document-type="chapter">Variegate Porphyria</related-object>.)</p>
          </list-item>
        </list>
        <p>If the family history is negative or unavailable, sporadic epilepsies (i.e., those without a genetic cause) need to be included in the differential diagnosis, as does any cause of epilepsy with nonspecific imaging findings. Some general categories of injury to consider include the following [<xref ref-type="bibr" rid="gefs.REF.arzimanoglou.2004">Arzimanoglou et al 2004</xref>, <xref ref-type="bibr" rid="gefs.REF.roger.2006">Roger et al 2006</xref>]:</p>
        <list list-type="bullet">
          <list-item>
            <p>Trauma</p>
          </list-item>
          <list-item>
            <p>Hypoxia</p>
          </list-item>
          <list-item>
            <p>Sequelae of meningitis or hemorrhage</p>
          </list-item>
          <list-item>
            <p>Infectious or autoimmune cerebritis</p>
          </list-item>
          <list-item>
            <p>Vasculitis</p>
          </list-item>
          <list-item>
            <p>Paraneoplastic syndrome</p>
          </list-item>
          <list-item>
            <p>Toxins (including drug withdrawal)</p>
          </list-item>
          <list-item>
            <p>Endocrinopathy</p>
          </list-item>
        </list>
        <p>If the family history is positive for other individuals with epilepsy, the differential diagnosis includes the following inherited epilepsy syndromes [<xref ref-type="bibr" rid="gefs.REF.arzimanoglou.2004">Arzimanoglou et al 2004</xref>, <xref ref-type="bibr" rid="gefs.REF.roger.2006">Roger et al 2006</xref>]:</p>
        <list list-type="bullet">
          <list-item>
            <p>Benign familial neonatal seizures (see <related-object link-type="booklink" source-id="gene" document-id="bfns" document-type="chapter"><italic toggle="yes">KCNQ2</italic>-Related Disorders</related-object>, <related-object link-type="booklink" source-id="gene" document-id="kcnq3-dis" document-type="chapter"><italic toggle="yes">KCNQ3</italic>-Related Disorders</related-object>)</p>
          </list-item>
          <list-item>
            <p>Benign familial infantile seizures (see <related-object link-type="booklink" source-id="gene" document-id="kcnq3-dis" document-type="chapter"><italic toggle="yes">KCNQ3-</italic>Related Disorders</related-object>)</p>
          </list-item>
          <list-item>
            <p>Benign childhood epilepsy with centrotemporal spikes (rolandic epilepsy) (see <related-object link-type="booklink" source-id="gene" document-id="bfns" document-type="chapter"><italic toggle="yes">KCNQ2</italic>-Related Disorders</related-object>, <related-object link-type="booklink" source-id="gene" document-id="kcnq3-dis" document-type="chapter"><italic toggle="yes">KCNQ3</italic>-Related Disorders</related-object>)</p>
          </list-item>
          <list-item>
            <p>Childhood occipital epilepsy</p>
          </list-item>
          <list-item>
            <p>Absence epilepsies</p>
          </list-item>
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="adnfle" document-type="chapter">Autosomal dominant nocturnal frontal lobe epilepsy</related-object>
            </p>
          </list-item>
          <list-item>
            <p>Familial temporal lobe epilepsies</p>
          </list-item>
          <list-item>
            <p>Familial focal epilepsy with variable foci</p>
          </list-item>
          <list-item>
            <p>Generalized epilepsy with febrile seizures plus (GEFS+)</p>
          </list-item>
        </list>
        <p>To date, at least 12 loci associated with familial febrile seizures and at least eight loci associated with generalized epilepsy febrile seizures plus (GEFS+) have been identified. The phenotype in simple febrile seizures is usually less severe than that of febrile seizures associated with GEFS+ (see <xref ref-type="sec" rid="gefs.Clinical_Description">Clinical Description</xref>) [<xref ref-type="bibr" rid="gefs.REF.nakayama.2006.s190">Nakayama &#x00026; Arinami 2006</xref>].</p>
        <p>See OMIM Phenotypic Series: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/phenotypicSeries/PS121210">Seizures, familial febrile</ext-link> and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/phenotypicSeries/PS604233">Epilepsy, generalized, with febrile seizures</ext-link> plus to view genes associated with this phenotype in OMIM.</p>
        <p>Genetic loci known to be associated with GEFS+ include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Voltage-gated sodium channel genes</p>
            <list list-type="bullet">
              <list-item>
                <p><italic toggle="yes">SCN1A</italic> (locus name: GEFSP2) [<xref ref-type="bibr" rid="gefs.REF.escayg.2000.343">Escayg et al 2000</xref>, <xref ref-type="bibr" rid="gefs.REF.escayg.2001.866">Escayg et al 2001</xref>, <xref ref-type="bibr" rid="gefs.REF.wallace.2001b.859">Wallace et al 2001b</xref>]</p>
              </list-item>
              <list-item>
                <p><italic toggle="yes">SCN1B</italic> (locus name: GEFSP1) [<xref ref-type="bibr" rid="gefs.REF.wallace.1998.366">Wallace et al 1998</xref>, <xref ref-type="bibr" rid="gefs.REF.wallace.2002.1426">Wallace et al 2002</xref>, <xref ref-type="bibr" rid="gefs.REF.audenaert.2003.854">Audenaert et al 2003</xref>], mutation of which may be an autosomal recessive cause of Dravet syndrome [<xref ref-type="bibr" rid="gefs.REF.patino.2009.10764">Patino et al 2009</xref>], with later onset than that associated with <italic toggle="yes">SCN1A</italic> or <italic toggle="yes">GABRG2</italic> [<xref ref-type="bibr" rid="gefs.REF.sijben.2009.953">Sijben et al 2009</xref>]</p>
              </list-item>
              <list-item>
                <p><italic toggle="yes">SCN2A</italic> [<xref ref-type="bibr" rid="gefs.REF.sugawara.2001.6384">Sugawara et al 2001</xref>], mutation of which can also cause a phenotype with severe myoclonic epilepsy, ataxia, and pain [<xref ref-type="bibr" rid="gefs.REF.liao.2010.1454">Liao et al 2010</xref>]. In children with Dravet syndrome, pathogenic variants in <italic toggle="yes">SCN1A</italic> are more frequently identified than pathogenic variants in <italic toggle="yes">SCN2A</italic> by a ratio of about 9:1 [<xref ref-type="bibr" rid="gefs.REF.shi.2009.758">Shi et al 2009</xref>].</p>
              </list-item>
              <list-item>
                <p>Occasionally, isolated
<italic toggle="yes">SCN9A</italic> pathogenic variants (without <italic toggle="yes">SCN1A</italic> alterations) associated with Dravet Syndrome [<xref ref-type="bibr" rid="gefs.REF.singh.2009.e1000649">Singh et al 2009</xref>]; the frequency of this occurrence is unknown. Familial studies have shown a relatively high occurrence of <italic toggle="yes">SCN9A</italic> pathogenic variants in individuals with Dravet syndrome in whom an <italic toggle="yes">SCN1A</italic> pathogenic variant has not been identified.</p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p>GABA<sub>A</sub> receptor genes</p>
            <list list-type="bullet">
              <list-item>
                <p><italic toggle="yes">GABRG2</italic> (locus name: GEFSP3) [<xref ref-type="bibr" rid="gefs.REF.baulac.2001.46">Baulac et al 2001</xref>, <xref ref-type="bibr" rid="gefs.REF.wallace.2001a.49">Wallace et al 2001a</xref>], which is much less common than <italic toggle="yes">SCN1A</italic>. <xref ref-type="bibr" rid="gefs.REF.shi.2010.375">Shi et al [2010]</xref> found one of 140 individuals with childhood epilepsy in the Dravet-GEFS+ spectrum with a <italic toggle="yes">GABRG2</italic> pathogenic variant.</p>
              </list-item>
              <list-item>
                <p><italic toggle="yes">GABRD</italic> (locus name: GEFSP5) [<xref ref-type="bibr" rid="gefs.REF.dibbens.2004.1315">Dibbens et al 2004</xref>]</p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p><italic toggle="yes">PCDH19,</italic> encoding protocadherin [<xref ref-type="bibr" rid="gefs.REF.depienne.2009.e1000381">Depienne et al 2009</xref>, <xref ref-type="bibr" rid="gefs.REF.marini.2010.646">Marini et al 2010</xref>] and located on the X chromosome. Mutation of <italic toggle="yes">PCDH19</italic> can cause a Dravet syndrome phenotype; most symptomatic individuals are female. The syndrome is characterized by early normal development followed by febrile and temperature-induced seizures that tend to occur in clusters. The onset of seizures tends to be a little later (age &#x02265;12 months). Although these individuals may have fewer myoclonic jerks and absence seizures than individuals with an <italic toggle="yes">SCN1A</italic> pathogenic variant, the phenotype may be quite similar to that of Dravet syndrome; furthermore, these individuals often respond to the same medications (e.g., stiripentol) [<xref ref-type="bibr" rid="gefs.REF.nikanorova.2011">Nikanorova et al 2011</xref>].</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">GEFSP6</italic> (8p23-p21), a region with no known ion channel genes [<xref ref-type="bibr" rid="gefs.REF.baulac.2008.943">Baulac et al 2008</xref>]</p>
          </list-item>
        </list>
        <p>Persons with seizures who have a 2q24.2 deletion may have a deletion of <italic toggle="yes">SCN1A</italic> or the candidate gene <italic toggle="yes">SLC4A10</italic> [<xref ref-type="bibr" rid="gefs.REF.krepischi.2010.2457">Krepischi et al 2010</xref>].</p>
      </sec>
      <sec id="gefs.Management">
        <title>Management</title>
        <sec id="gefs.Evaluations_Following_Initial_Diagn">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with an <italic toggle="yes">SCN1A</italic>-related seizure disorder, the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Neurologic examination</p>
            </list-item>
            <list-item>
              <p>Cognitive neuropsychological evaluation</p>
            </list-item>
            <list-item>
              <p>Behavioral neuropsychological evaluation</p>
            </list-item>
            <list-item>
              <p>Electroencephalogram (EEG), including video EEG telemetry where ictal onset or semiology is unclear</p>
            </list-item>
            <list-item>
              <p>Clinical genetics evaluation [<xref ref-type="bibr" rid="gefs.REF.pal.2010.445">Pal et al 2010</xref>]</p>
            </list-item>
          </list>
        </sec>
        <sec id="gefs.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Care is best provided by a physician (e.g., pediatric epileptologist) familiar with the pharmacotherapy for this disorder. Seizure control is critical because children with <italic toggle="yes">SCN1A</italic>-related seizure disorder are at high risk for sudden unexplained death in epilepsy (SUDEP). In addition, prolonged acute seizures may cause permanent injury [<xref ref-type="bibr" rid="gefs.REF.chipaux.2010.190">Chipaux et al 2010</xref>, <xref ref-type="bibr" rid="gefs.REF.takayanagi.2010.1886">Takayanagi et al 2010</xref>].</p>
          <p>Pharmacologic treatment focuses on the observations that abnormal SCN1A channels disproportionately affect GABA neurons [<xref ref-type="bibr" rid="gefs.REF.yu.2006.1142">Yu et al 2006</xref>] and that the associated seizures respond optimally to antiepileptic drugs (AEDs) that bind to the GABA receptor:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Clobazam (0.2-1 mg mg/kg/day),</bold> part of the standard of care in Europe, is now approved by the FDA in the US. Clobazam is FDA approved for the treatment of seizures in Lennox-Gastaut syndrome [<xref ref-type="bibr" rid="gefs.REF.selmer.2009.555">Selmer et al 2009</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Stiripentol (30-100 mg/kg/day)</bold> is accepted by epileptologists as an effective therapeutic agent in <italic toggle="yes">SCN1A</italic>-related seizure disorders. It is part of the early standard of care in Europe, and is used in the US after other conventional anticonvulsants have failed. It is not approved by the FDA for use in the US, but the evidence of effectiveness in <italic toggle="yes">SCN1A</italic>-related epilepsy is more specific than for any other agent (based on double-blind evaluation of seizure reduction in severe myoclonic epilepsy in infancy (SMEI) [<xref ref-type="bibr" rid="gefs.REF.chiron.2000.1638">Chiron et al 2000</xref>]). As a result, stiripentol is not considered an &#x0201c;investigational&#x0201d; therapy. <xref ref-type="bibr" rid="gefs.REF.thanh.2002.1120">Thanh et al [2002]</xref> demonstrated efficacy of the drug when compared with placebo; only moderate side effects including drowsiness, loss of appetite, and occasional neutropenia in infants and young children were observed. In a recent US survey of 82 children with Dravet syndrome, stiripentol was found to be effective in reducing prolonged seizures [<xref ref-type="bibr" rid="gefs.REF.wirrell.2013.1595">Wirrell et al 2013</xref>].Stiripentol, which acts directly on GABA<sub>A</sub> receptors [<xref ref-type="bibr" rid="gefs.REF.quilichini.2006.704">Quilichini et al 2006</xref>], is also a potent inhibitor of the hepatic enzymes CYP3A4, CYP1A2, and CYP2C19. As a result, it increases the serum concentration of several common AEDs, including valproic acid, clobazam, and its metabolite nor-clobazam [<xref ref-type="bibr" rid="gefs.REF.thanh.2002.1120">Thanh et al 2002</xref>]. Doses above 50 mg/kg/day are usually not tolerated when used in conjunction with valproic acid and clobazam.Children older than age 12 years may not tolerate stiripentol because of digestive tract side effects and nausea [<xref ref-type="bibr" rid="gefs.REF.thanh.2002.1120">Thanh et al 2002</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Benzodiazepines.</bold> Individuals taking stiripentol must exercise caution in the use of benzodiazepines [<xref ref-type="bibr" rid="gefs.REF.thanh.2002.1120">Thanh et al 2002</xref>]. A single infusion of diazepam and clonazepam appears to be safe [<xref ref-type="bibr" rid="gefs.REF.thanh.2002.1120">Thanh et al 2002</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Topiramate</bold> [<xref ref-type="bibr" rid="gefs.REF.coppola.2002.45">Coppola et al 2002</xref>]</p>
            </list-item>
            <list-item>
              <p><bold>Valproic acid</bold> (10-30 mg/kg/day) [<xref ref-type="bibr" rid="gefs.REF.thanh.2002.1120">Thanh et al 2002</xref>]</p>
            </list-item>
            <list-item>
              <p><bold>Ethosuximide.</bold> Can be effective for absence seizures. The dose is usually limited by gastrointestinal side effects, which can be minimized by more frequent dosing.</p>
            </list-item>
            <list-item>
              <p><bold>Levetiracetam</bold> (20-80 mg/kg/day). Often effective, but may make seizures worse in some individuals [<xref ref-type="bibr" rid="gefs.REF.caraballo.2010.146">Caraballo et al 2010</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Potassium bromide.</bold> Not FDA-approved in the US, but widely used in Japan with reasonable effectiveness [<xref ref-type="bibr" rid="gefs.REF.tanabe.2008.629">Tanabe et al 2008</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Phenobarbital.</bold> Although effective, phenobarbital is poorly tolerated because of its effects on cognition. When it is taken in combination with stiripentol, the serum concentration of phenobarbital is increased because stiripentol slows the metabolism and excretion of barbiturates.</p>
            </list-item>
            <list-item>
              <p><bold>Ketogenic diet.</bold>
<xref ref-type="bibr" rid="gefs.REF.dressler.2010.404">Dressler et al [2010]</xref> report that seizures were reduced by more than 50% in 62.5% of persons with Dravet syndrome who stayed on the diet for six months. The findings of <xref ref-type="bibr" rid="gefs.REF.nabbout.2011.e54">Nabbout et al [2011]</xref> in 15 individuals also support the use of the ketogenic diet in Dravet syndrome.</p>
            </list-item>
          </list>
          <p>Sleep deprivation and illness can exacerbate <italic toggle="yes">SCN1A</italic>-related seizures; thus, good sleep hygiene should be encouraged. Comorbidity with sleep apnea can also occur frequently in individuals with epilepsy [<xref ref-type="bibr" rid="gefs.REF.malow.2000.1002">Malow et al 2000</xref>], and can influence seizure control, behavior, and cognition. Polysomnography should be considered if obstructive or central sleep apnea is suspected.</p>
          <p>Due to the sedating effects of seizure medications and the possibility of respiratory depression (especially with benzodiazepines and barbiturates), parents are advised to take a CPR course. Routine seizure and personal safety counseling is indicated.</p>
          <p>Seizures are not always responsive to conventional AEDs. Anecdotal evidence suggests that the following drugs/treatment modalities may be effective for <italic toggle="yes">SCN1A</italic>-related SMEI seizures [<xref ref-type="bibr" rid="gefs.REF.dravet.2002">Dravet et al 2002</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p>Ethosuximide and high-dose piracetam for myoclonic seizures</p>
            </list-item>
            <list-item>
              <p>Corticosteroids</p>
            </list-item>
            <list-item>
              <p>Immunoglobulins</p>
            </list-item>
          </list>
          <p>Non-medical interventions that families have reported to be helpful include the following [<xref ref-type="bibr" rid="gefs.REF.nolan.2008.690">Nolan et al 2008</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p>Placement of an indwelling venous access device</p>
            </list-item>
            <list-item>
              <p>Creating a portable microenvironment</p>
            </list-item>
            <list-item>
              <p>Having a written emergency department protocol</p>
            </list-item>
            <list-item>
              <p>Establishing emergency routines for the family</p>
            </list-item>
            <list-item>
              <p>Assigning a parent on call to lessen the effect on the siblings</p>
            </list-item>
            <list-item>
              <p>Creating personal time to decrease parent stress</p>
            </list-item>
            <list-item>
              <p>Finding respite care</p>
            </list-item>
            <list-item>
              <p>Contacting an internet support group</p>
            </list-item>
          </list>
        </sec>
        <sec id="gefs.Prevention_of_Secondary_Complicatio">
          <title>Prevention of Secondary Complications</title>
          <p>Individuals experiencing atonic seizures or myoclonic-astatic epilepsy should be advised to wear a protective helmet.</p>
          <p>Although immunization may trigger a seizure, it does not affect the natural course of the disorder. <xref ref-type="bibr" rid="gefs.REF.mcintosh.2010.592">McIntosh et al [2010]</xref> looked retrospectively at a cohort of 14 individuals with Dravet syndrome, and found no effect of immunization on cognitive outcome. These authors suggest that the immunization schedule not be altered and that the risk for fever following immunization could be reduced by providing a scheduled, long-acting NSAID (e.g., naproxen). The treating neurologist may also consider increasing the anticonvulsant dose(s) temporarily around the time of the immunization.</p>
        </sec>
        <sec id="gefs.Surveillance">
          <title>Surveillance</title>
          <p>Serial neuropsychological evaluation for neurologic, cognitive, and behavioral deterioration is appropriate.</p>
          <p>EEG monitoring is appropriate when new or different seizure types are suspected.</p>
        </sec>
        <sec id="gefs.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Several antiepileptic drugs (AEDs) which are effective for most forms of epilepsy can make seizures due to heterozygous <italic toggle="yes">SCN1A</italic> pathogenic variants worse:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Carbamazepine, lamotrigine, and vigabatrin,</bold> which can induce or increase myoclonic seizures [<xref ref-type="bibr" rid="gefs.REF.horn.1986.340">Horn et al 1986</xref>, <xref ref-type="bibr" rid="gefs.REF.guerrini.1998.508">Guerrini et al 1998</xref>, <xref ref-type="bibr" rid="gefs.REF.ceulemans.2004a.516">Ceulemans et al 2004a</xref>]</p>
            </list-item>
            <list-item>
              <p><bold>Phenytoin,</bold> which may worsen seizures and can induce choreoathetosis [<xref ref-type="bibr" rid="gefs.REF.saito.2001.231">Saito et al 2001</xref>]</p>
            </list-item>
            <list-item>
              <p><bold>Rufinamide,</bold> which has a pharmacologic mechanism similar to carbamazepine and phenytoin and may exacerbate seizures as well</p>
            </list-item>
            <list-item>
              <p><bold>Acetaminophen,</bold> which is hepatotoxic in overdose. Given the possibility of interaction with anticonvulsant medications, especially valproate and topiramate [<xref ref-type="bibr" rid="gefs.REF.nicolai.2008.92">Nicolai et al 2008</xref>], acetaminophen should be avoided. Any of the NSAIDs are effective as antipyretics, and represent much lower risk.</p>
            </list-item>
          </list>
          <p>Activities in which a sudden loss of consciousness could lead to injury or death should be avoided (e.g., bathing, swimming, driving, or working/playing at heights).</p>
        </sec>
        <sec id="gefs.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="gefs.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="gefs.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>In addition to the considerations described in <xref ref-type="sec" rid="gefs.Genetic_Counseling">Genetic Counseling</xref>, other pregnancy-related considerations include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Risk of major malformations (especially due to valproic acid exposure in utero [<xref ref-type="bibr" rid="gefs.REF.samr_n.1997.981">Samr&#x000e9;n et al 1997</xref>]) and minor anomalies</p>
            </list-item>
            <list-item>
              <p>Advantages and disadvantages of increasing maternal periconceptional folic acid supplementation to 4000 &#x000b5;g daily, particularly when women are taking valproic acid or carbamazepine during pregnancy</p>
            </list-item>
            <list-item>
              <p>Effect of in utero exposure to anticonvulsants on future cognitive development [<xref ref-type="bibr" rid="gefs.REF.meador.2009.1597">Meador et al 2009</xref>]</p>
            </list-item>
            <list-item>
              <p>Effect of anticonvulsants on hormonal methods of birth control</p>
            </list-item>
            <list-item>
              <p>Effects of anticonvulsants on conception; the risk for complications in mothers who are on anticonvulsants</p>
            </list-item>
            <list-item>
              <p>Effect of pregnancy on anticonvulsant metabolism</p>
            </list-item>
            <list-item>
              <p>Effect of pregnancy on maternal seizure control</p>
            </list-item>
          </list>
          <p>Pregnancy, family planning, and contraception are issues that should be raised with every female near childbearing age who has epilepsy. These considerations are not unique to or (aside from medication selection) significantly influenced by the presence of an <italic toggle="yes">SCN1A</italic>-related seizure disorder.</p>
        </sec>
        <sec id="gefs.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p><bold>Cannabis-derived compounds</bold> (including cannabidiol [CBD], tetrahydrocannabinol [THC], and marijuana oils), collectively called &#x0201c;cannabinoids,&#x0201d; have received much attention from the media based on anecdotal experiences; however, there is currently no scientific evidence that they are effective. As a result, they should never be used in place of treatments that are known to be effective. A randomized clinical trial is required to determine whether cannabinoid treatment is effective. There has been rapid progress in starting such a trial, and it is expected to begin in 2014. Cannabinoids are bioactive and may have psychotropic and/or systemic side effects; they also may act as an immunosuppressant and an anti-inflammatory in animal models and thus should be studied carefully in immature humans before widespread use is considered [<xref ref-type="bibr" rid="gefs.REF.rieder.2010.598">Rieder et al 2010</xref>, <xref ref-type="bibr" rid="gefs.REF.bergamaschi.2011.237">Bergamaschi et al 2011</xref>].</p>
          <p><bold>Thalamic deep brain stimulation (DBS)</bold> was reported by <xref ref-type="bibr" rid="gefs.REF.andrade.2010.1314">Andrade et al [2010]</xref> in two children with Dravet syndrome with ten-year follow up. One showed &#x0201c;marked improvement&#x0201d; after implantation, whereas the other received no benefit.</p>
          <p><bold>Lacosamide</bold> has not been studied in <italic toggle="yes">SCN1A</italic>-related seizure disorders; however, there are theoretic reasons why it may be effective [<xref ref-type="bibr" rid="gefs.REF.curia.2009.555">Curia et al 2009</xref>].</p>
          <p><bold>Verapamil</bold> was reported to help two girls with severe epilepsy resulting from mutation of <italic toggle="yes">SCN1A</italic> [<xref ref-type="bibr" rid="gefs.REF.iannetti.2009.89">Iannetti et al 2009</xref>]; however, it has not been formally studied.</p>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
        <sec id="gefs.Other">
          <title>Other</title>
          <p>Persons with epilepsy should be made aware of local motor vehicle driving laws and physician reporting laws.</p>
          <p>Hippocampal sclerosis can occur as a secondary feature of <italic toggle="yes">SCN1A</italic>-related seizure disorders [<xref ref-type="bibr" rid="gefs.REF.livingston.2009.503">Livingston et al 2009</xref>], but there is no proven role for surgery given the widespread epileptogenic potential in this disorder. Of note, <xref ref-type="bibr" rid="gefs.REF.scheffer.2007.100">Scheffer et al [2007]</xref> reported good outcomes after temporal lobe surgery in two persons with mutation of <italic toggle="yes">SCN1B</italic>.</p>
        </sec>
      </sec>
      <sec id="gefs.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="gefs.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p><italic toggle="yes">SCN1A</italic>-related seizure disorders are inherited in an autosomal dominant manner.</p>
          <p>Note: Most <italic toggle="yes">SCN1A</italic>-related severe myoclonic epilepsy in infancy (SMEI) and intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC) are the result of a <italic toggle="yes">de novo</italic> heterozygous pathogenic variant.</p>
        </sec>
        <sec id="gefs.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>A parent of the proband is presumed to have an <italic toggle="yes">SCN1A</italic> pathogenic variant if he/she has additional family members who have seizures.</p>
            </list-item>
            <list-item>
              <p>A proband with an <italic toggle="yes">SCN1A</italic>-related seizure disorder may have the disorder as the result of a <italic toggle="yes">de novo</italic> pathogenic variant. The proportion of cases caused by <italic toggle="yes">de novo</italic> variants differs by phenotype. The percentage of probands with an <italic toggle="yes">SCN1A</italic>-related seizure disorder and an affected parent decreases as the severity of the phenotype in the proband increases.</p>
              <list list-type="bullet">
                <list-item>
                  <p>More than 95% of individuals with GEFS+ have a parent with the same <italic toggle="yes">SCN1A</italic> pathogenic variant.</p>
                </list-item>
                <list-item>
                  <p>Only approximately 5% of probands with SMEI have a parent with the same <italic toggle="yes">SCN1A</italic> pathogenic variant [<xref ref-type="bibr" rid="gefs.REF.wallace.2003.765">Wallace et al 2003</xref>, <xref ref-type="bibr" rid="gefs.REF.ceulemans.2004b.236">Ceulemans et al 2004b</xref>, <xref ref-type="bibr" rid="gefs.REF.fukuma.2004.140">Fukuma et al 2004</xref>].</p>
                </list-item>
                <list-item>
                  <p>Testing of parents of children who had SMEI and a confirmed <italic toggle="yes">SCN1A</italic> pathogenic variant showed that in 95% (76/80) of the children the pathogenic variant was <italic toggle="yes">de novo</italic> in the proband. Of the four children who had a parent with the pathogenic variant, two had a missense variant and two had a truncation variant; the parents were either asymptomatic or had mild epilepsy [<xref ref-type="bibr" rid="gefs.REF.gennaro.2003.21">Gennaro et al 2003</xref>, <xref ref-type="bibr" rid="gefs.REF.nabbout.2003.1961">Nabbout et al 2003</xref>].</p>
                </list-item>
                <list-item>
                  <p><xref ref-type="bibr" rid="gefs.REF.berkovic.2006.488">Berkovic et al [2006]</xref> found an <italic toggle="yes">SCN1A</italic> pathogenic variant in 11/14 children diagnosed with post-vaccine encephalopathy; in nine the variant was <italic toggle="yes">de novo</italic> in the proband.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>If a pathogenic variant found in the proband cannot be detected in DNA extracted from the leukocytes of either parent, the risk to either parent of having the pathogenic variant is low, but greater than that of the general population because of the possibility of germline mosaicism. Germline mosaicism has been documented [<xref ref-type="bibr" rid="gefs.REF.gennaro.2006.489">Gennaro et al 2006</xref>, <xref ref-type="bibr" rid="gefs.REF.selmer.2009.555">Selmer et al 2009</xref>, <xref ref-type="bibr" rid="gefs.REF.azmanov.2010.117">Azmanov et al 2010</xref>], and may occur in up to 7% of families with Dravet syndrome [<xref ref-type="bibr" rid="gefs.REF.depienne.2010.404">Depienne et al 2010</xref>].</p>
            </list-item>
            <list-item>
              <p>In one series, 75% of <italic toggle="yes">de novo</italic> pathogenic variants originated on the paternally inherited chromosome [<xref ref-type="bibr" rid="gefs.REF.heron.2010.137">Heron et al 2010</xref>].</p>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of parents of a proband with an apparent <italic toggle="yes">de novo</italic> pathogenic variant include molecular genetic testing.</p>
            </list-item>
            <list-item>
              <p>An apparently negative family history cannot be confirmed until appropriate evaluations have been performed. Although 95% of individuals with <italic toggle="yes">SCN1A</italic>-related GEFS+ have an affected parent, the family history may appear to be negative because of failure to recognize the disorder in family members or because of early death before the onset of symptoms. If the parent is the individual in whom the pathogenic variant first occurred, s/he may have somatic mosaicism for the pathogenic variant and may be only mildly or minimally affected [<xref ref-type="bibr" rid="gefs.REF.gennaro.2006.489">Gennaro et al 2006</xref>].</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of a proband depends on the genetic status of the proband's parents: if a parent of the proband is affected (i.e., has the pathogenic variant documented by molecular genetic testing) or is presumed to have a pathogenic variant (based on family history), the risk to the sibs of inheriting the pathogenic variant is 50%.</p>
            </list-item>
            <list-item>
              <p>If a sib has epilepsy, he/she is presumed to be affected (and therefore to have a pathogenic variant).</p>
            </list-item>
            <list-item>
              <p>If a sib does not have epilepsy, the prior probability of the sib having inherited the pathogenic variant is 50%; however, the probability of the sib developing symptoms depends on the penetrance, which can only be estimated. For example, for an estimated penetrance of 70% for the GEFS+ phenotype, the probability of the asymptomatic sib having inherited the pathogenic variant is 23%.</p>
            </list-item>
            <list-item>
              <p>If a pathogenic variant is found in the proband but cannot be detected in the DNA of either parent, the risk to sibs is low but greater than that of the general population because of the possibility of germline mosaicism [<xref ref-type="bibr" rid="gefs.REF.gennaro.2006.489">Gennaro et al 2006</xref>].</p>
            </list-item>
          </list>
          <p>
            <bold>Offspring of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Each child of an individual with an <italic toggle="yes">SCN1A</italic>-related seizure disorder has a 50% chance of inheriting the pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>Penetrance is incomplete (see <xref ref-type="sec" rid="gefs.Penetrance">Penetrance</xref>) and varies by phenotype.</p>
            </list-item>
            <list-item>
              <p>The likelihood that the child of an individual with an <italic toggle="yes">SCN1A</italic>-related seizure disorder will develop the same phenotype is the probability of inheriting the pathogenic variant (50%) times the penetrance for that particular phenotype.</p>
            </list-item>
            <list-item>
              <p>Individuals with GEFS+ may have offspring who are more severely affected than they are. For example, they may have a child with Dravet syndrome.</p>
            </list-item>
          </list>
          <p><bold>Other family members of a proband.</bold> The risk to other family members depends on the status of the proband's parents: if a parent is affected or has a pathogenic variant, the other family members are at greater risk than the general population.</p>
        </sec>
        <sec id="gefs.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p><bold>Interpreting test results in at-risk asymptomatic relatives.</bold> Counseling asymptomatic family members who are identified to have the family-specific pathogenic variant should include information on reduced penetrance and the limited ability to predict phenotype based on molecular genetic testing alone.</p>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</bold> When neither parent of a proband with an autosomal dominant condition has the pathogenic variant or clinical evidence of the disorder, the variant is likely <italic toggle="yes">de novo</italic>. However, possible non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="gefs.Prenatal_Testing_and_Preimplantatio">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">SCN1A</italic> pathogenic variant has been identified in an affected family member, prenatal testing and preimplantation genetic diagnosis for a pregnancy at increased risk for a <italic toggle="yes">SCN1A</italic>-related seizure disorder are possible options.</p>
        </sec>
      </sec>
      <sec id="gefs.Resources">
        <title>Resources</title>
      </sec>
      <sec id="gefs.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="gefs.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p><italic toggle="yes">SCN1A</italic> encodes the alpha subunit (also known as Na<sub>v</sub>1.1) of the neuronal voltage-gated sodium channel. <italic toggle="yes">SCN1A</italic>-related seizure disorders are therefore best conceptualized as a "channelopathy" with seizures (and their sequelae) as their primary manifestation. The molecular abnormality causes neuronal dysfunction, and ultimately hyperexcitability at the level of the cortical network: the sine qua non of epilepsy.</p>
          <p><italic toggle="yes">SCN1A</italic> is part of a cluster of sodium channel genes encoded on chromosome 2q24 that includes <italic toggle="yes">SCN2A</italic> and <italic toggle="yes">SCN3A</italic> [<xref ref-type="bibr" rid="gefs.REF.mulley.2005.535">Mulley et al 2005</xref>]. The alpha subunit of sodium channels forms the membrane pore. Each alpha subunit protein has four domains with six transmembrane segments connected by loops (<xref ref-type="fig" rid="gefs.F2">Figure 2</xref>). Pore-lining residues are found in S5, S6, and the P-loop, the latter connecting S5 with S6. The voltage sensor is in S4, where positively charged residues allow for the sensing of membrane potential changes [<xref ref-type="bibr" rid="gefs.REF.catterall.2000.13">Catterall 2000</xref>]. Although epilepsy-associated pathogenic variants are found in all parts of Na<sub>v</sub>1.1, they occur more frequently in the C-terminus, to some extent in the N-terminus, in the P-loops of D1-D5, and in the voltage sensor [<xref ref-type="bibr" rid="gefs.REF.ceulemans.2004b.236">Ceulemans et al 2004b</xref>, <xref ref-type="bibr" rid="gefs.REF.mulley.2006.1094">Mulley et al 2006</xref>].</p>
          <p><bold>Gene structure.</bold>
<italic toggle="yes">SCN1A</italic> spans approximately 84 Mb of genomic DNA and has a transcript of 8,100 bp (reference sequence <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&#x00026;id=115583676">NM_006920.4</ext-link>). The gene comprises 26 exons that encode a protein of 1,998 amino acid residues (reference sequence <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=protein&#x00026;id=115583677">NP_008851.3</ext-link>). Splicing variability has been reported [<xref ref-type="bibr" rid="gefs.REF.wallace.2001b.859">Wallace et al 2001b</xref>]. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="gefs" object-id="gefs.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
          <p>
            <bold>Pathogenic allelic variants</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Generalized epilepsy with febrile seizures plus (GEFS+).</bold>
<italic toggle="yes">SCN1A</italic> pathogenic variants associated with GEFS+ are mostly missense and familial (i.e., inherited) [<xref ref-type="bibr" rid="gefs.REF.mulley.2005.535">Mulley et al 2005</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Dravet syndrome.</bold> Almost half the pathogenic variants associated with the severe myoclonic epilepsy in infancy (SMEI) phenotype are truncating variants [<xref ref-type="bibr" rid="gefs.REF.mulley.2006.1094">Mulley et al 2006</xref>]. The remainder includes missense variants (39%-43%; fewer than the GEFS+ phenotype, but with a similar topologic distribution within Na<sub>v</sub>1.1), splice site variants (7%), and deletions (3%) [adapted from <xref ref-type="bibr" rid="gefs.REF.mulley.2005.535">Mulley et al 2005</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC).</bold> Seven out of ten individuals with ICE-GTC had an <italic toggle="yes">SCN1A</italic> missense pathogenic variant [<xref ref-type="bibr" rid="gefs.REF.mulley.2005.535">Mulley et al 2005</xref>]. In the two cases with an inherited pathogenic variant, the parents had GEFS+.</p>
            </list-item>
            <list-item>
              <p><bold>Infantile partial seizures with variable foci.</bold> In the authors' experience, such cases often have missense pathogenic variants affecting the pore region or the carboxy-terminus of Na<sub>v</sub>1.1.</p>
            </list-item>
            <list-item>
              <p><bold>Infantile spasms.</bold> The literature cites an isolated case of infantile spasms and an <italic toggle="yes">SCN1A</italic> missense pathogenic variant [<xref ref-type="bibr" rid="gefs.REF.wallace.2003.765">Wallace et al 2003</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Vaccine-related encephalopathy and seizures.</bold> There are five reports of pathogenic variants causing Na<sub>v</sub>1.1 truncation and six reports of missense pathogenic variants in conserved regions of Na<sub>v</sub>1.1 [<xref ref-type="bibr" rid="gefs.REF.berkovic.2006.488">Berkovic et al 2006</xref>].</p>
            </list-item>
          </list>
          <p><bold>Normal gene product.</bold> See <xref ref-type="sec" rid="gefs.Molecular_Genetic_Pathogenesis">Molecular Genetic Pathogenesis</xref>.</p>
          <p><bold>Abnormal gene product.</bold> The molecular pathogenesis of <italic toggle="yes">SCN1A-</italic>related seizure disorders may vary depending on the specific pathogenic variant type (loss of function vs. alteration in activity). The pathophysiology is an active area of investigation; it appears likely that the predominant effect is the loss of excitability in inhibitory GABAergic neurons [<xref ref-type="bibr" rid="gefs.REF.escayg.2010.1650">Escayg &#x00026; Goldin 2010</xref>].</p>
        </sec>
      </sec>
      <sec id="gefs.References">
        <title>References</title>
        <sec id="gefs.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="gefs.Literature_Cited.reflist0">
            <ref id="gefs.REF.akiyama.2010.1043">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Akiyama</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kobayashi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshinaga</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohtsuka</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>A long-term follow-up study of Dravet syndrome up to adulthood.</article-title>
                <source>Epilepsia.</source>
                <volume>51</volume>
                <fpage>1043</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">20041943</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.andrade.2010.1314">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Andrade</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamani</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lozano</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wennberg</surname>
                    <given-names>RA</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Dravet syndrome and deep brain stimulation: seizure control after 10 years of treatment.</article-title>
                <source>Epilepsia.</source>
                <volume>51</volume>
                <fpage>1314</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">19919661</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.arzimanoglou.2004">
              <mixed-citation publication-type="book">Arzimanoglou A, Guerrini R, Aicardi J. <italic toggle="yes">Aicardi's Epilepsy in Children</italic>. 3 ed. Philadephia, PA: Lippincott Williams &#x00026; Wilkins; 2004.</mixed-citation>
            </ref>
            <ref id="gefs.REF.audenaert.2003.854">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Audenaert</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Claes</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ceulemans</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lofgren</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Broeckhoven</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Jonghe</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>A deletion in SCN1B is associated with febrile seizures and early-onset absence epilepsy.</article-title>
                <source>Neurology</source>
                <volume>61</volume>
                <fpage>854</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">14504340</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.azmanov.2010.117">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Azmanov</surname>
                    <given-names>DN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhelyazkova</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dimova</surname>
                    <given-names>PS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Radionova</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bojinova</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Florez</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tournev</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jablensky</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulley</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalaydjieva</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sander</surname>
                    <given-names>JW</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Mosaicism of a missense SCN1A mutation and Dravet syndrome in a Roma/Gypsy family.</article-title>
                <source>Epileptic Disord.</source>
                <volume>12</volume>
                <fpage>117</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">20562086</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.baulac.2008.943">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Baulac</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gourfinkel-An</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Couarch</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Depienne</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaminska</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dulac</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baulac</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>LeGuern</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nabbout</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>A novel locus for generalized epilepsy with febrile seizures plus in French families.</article-title>
                <source>Arch Neurol.</source>
                <volume>65</volume>
                <fpage>943</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">18625863</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.baulac.1999.1078">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Baulac</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gourfinkel-An</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Picard</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenberg-Bourgin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prud'homme</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baulac</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brice</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>LeGuern</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>A second locus for familial generalized epilepsy with febrile seizures plus maps to chromosome 2q21-q33.</article-title>
                <source>Am J Hum Genet</source>
                <volume>65</volume>
                <fpage>1078</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">10486327</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.baulac.2001.46">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Baulac</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huberfeld</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gourfinkel-An</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitropoulou</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beranger</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prud'homme</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baulac</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brice</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruzzone</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>LeGuern</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>First genetic evidence of GABA(A) receptor dysfunction in epilepsy: a mutation in the gamma2-subunit gene.</article-title>
                <source>Nat Genet</source>
                <volume>28</volume>
                <fpage>46</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11326274</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.bergamaschi.2011.237">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bergamaschi</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Queiroz</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zuardi</surname>
                    <given-names>AW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crippa</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <article-title>Safety and side effects of cannabidiol, a Cannabis sativa constituent.</article-title>
                <source>Curr Drug Saf.</source>
                <year>2011</year>
                <volume>6</volume>
                <fpage>237</fpage>
                <lpage>49</lpage>
                <pub-id pub-id-type="pmid">22129319</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.berkovic.2006.488">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harkin</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McMahon</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pelekanos</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zuberi</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wirrell</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gill</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iona</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulley</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>IE</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>De-novo mutations of the sodium channel gene SCN1A in alleged vaccine encephalopathy: a retrospective study.</article-title>
                <source>Lancet Neurol</source>
                <volume>5</volume>
                <fpage>488</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">16713920</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.bonanni.2004.149">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bonanni</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malcarne</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moro</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Veggiotti</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buti</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrari</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parrini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mei</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Volzone</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zara</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heron</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bordo</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guerrini</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Generalized epilepsy with febrile seizures plus (GEFS+): clinical spectrum in seven Italian families unrelated to SCN1A, SCN1B, and GABRG2 gene mutations.</article-title>
                <source>Epilepsia</source>
                <volume>45</volume>
                <fpage>149</fpage>
                <lpage>58</lpage>
                <pub-id pub-id-type="pmid">14738422</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.caraballo.2010.146">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Caraballo</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cers&#x000f3;simo</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De los Santos</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Levetiracetam-induced seizure aggravation associated with continuous spikes and waves during slow sleep in children with refractory epilepsies.</article-title>
                <source>Epileptic Disord.</source>
                <volume>12</volume>
                <fpage>146</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">20483715</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.catterall.2000.13">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Catterall</surname>
                    <given-names>WA</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels.</article-title>
                <source>Neuron</source>
                <volume>26</volume>
                <fpage>13</fpage>
                <lpage>25</lpage>
                <pub-id pub-id-type="pmid">10798388</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.catterall.2010.1849">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Catterall</surname>
                    <given-names>WA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalume</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oakley</surname>
                    <given-names>JC</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>NaV1.1 channels and epilepsy.</article-title>
                <source>J Physiol.</source>
                <volume>588</volume>
                <fpage>1849</fpage>
                <lpage>59</lpage>
                <pub-id pub-id-type="pmid">20194124</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.ceulemans.2004a.516">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ceulemans</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boel</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Claes</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dom</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Willekens</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thiry</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lagae</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2004a</year>
                <article-title>Severe myoclonic epilepsy in infancy: toward an optimal treatment.</article-title>
                <source>J Child Neurol</source>
                <volume>19</volume>
                <fpage>516</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">15526956</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.ceulemans.2004b.236">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ceulemans</surname>
                    <given-names>BP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Claes</surname>
                    <given-names>LR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lagae</surname>
                    <given-names>LG</given-names>
                  </name>
                </person-group>
                <year>2004b</year>
                <article-title>Clinical correlations of mutations in the SCN1A gene: from febrile seizures to severe myoclonic epilepsy in infancy.</article-title>
                <source>Pediatr Neurol</source>
                <volume>30</volume>
                <fpage>236</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">15087100</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.chipaux.2010.190">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chipaux</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Villeneuve</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sabouraud</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Desguerre</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boddaert</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Depienne</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chiron</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dulac</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nabbout</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Unusual consequences of status epilepticus in Dravet syndrome.</article-title>
                <source>Seizure.</source>
                <volume>19</volume>
                <fpage>190</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">20172746</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.chiron.2000.1638">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chiron</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marchand</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tran</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rey</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>d'Athis</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vincent</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dulac</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pons</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group.</article-title>
                <source>Lancet</source>
                <volume>356</volume>
                <fpage>1638</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">11089822</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.claes.2001.1327">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Claes</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Del-Favero</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ceulemans</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lagae</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Broeckhoven</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Jonghe</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy.</article-title>
                <source>Am J Hum Genet</source>
                <volume>68</volume>
                <fpage>1327</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">11359211</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.coppola.2002.45">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Coppola</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Capovilla</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montagnini</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romeo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tortorella</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Veggiotti</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Viri</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pascotto</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Topiramate as add-on drug in severe myoclonic epilepsy in infancy: an Italian multicenter open trial.</article-title>
                <source>Epilepsy Res</source>
                <volume>49</volume>
                <fpage>45</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11948006</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.curia.2009.555">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Curia</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biagini</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perucca</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Avoli</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Lacosamide: a new approach to target voltage-gated sodium currents in epileptic disorders.</article-title>
                <source>CNS Drugs.</source>
                <volume>23</volume>
                <fpage>555</fpage>
                <lpage>68</lpage>
                <pub-id pub-id-type="pmid">19552484</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.depienne.2009.e1000381">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Depienne</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bouteiller</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keren</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cheuret</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poirier</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trouillard</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benyahia</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quelin</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carpentier</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Julia</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Afenjar</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gautier</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rivier</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meyer</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berquin</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x000e9;lias</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Py</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rivera</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bahi-Buisson</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gourfinkel-An</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cazeneuve</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruberg</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brice</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nabbout</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leguern</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Sporadic infantile epileptic encephalopathy caused by mutations in PCDH19 resembles Dravet syndrome but mainly affects females.</article-title>
                <source>PLoS Genet.</source>
                <volume>5</volume>
                <fpage>e1000381</fpage>
                <pub-id pub-id-type="pmid">19214208</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.depienne.2010.404">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Depienne</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trouillard</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gourfinkel-An</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saint-Martin</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bouteiller</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graber</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barthez-Carpentier</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gautier</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Villeneuve</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dravet</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Livet</surname>
                    <given-names>MO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rivier-Ringenbach</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adam</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dupont</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baulac</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x000e9;ron</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nabbout</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leguern</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Mechanisms for variable expressivity of inherited SCN1A mutations causing Dravet syndrome.</article-title>
                <source>J Med Genet.</source>
                <volume>47</volume>
                <fpage>404</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">20522430</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.dibbens.2004.1315">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dibbens</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feng</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richards</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harkin</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hodgson</surname>
                    <given-names>BL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scott</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jenkins</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petrou</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sutherland</surname>
                    <given-names>GR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>IE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Macdonald</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulley</surname>
                    <given-names>JC</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>GABRD encoding a protein for extra- or peri-synaptic GABAA receptors is a susceptibility locus for generalized epilepsies.</article-title>
                <source>Hum Mol Genet.</source>
                <volume>13</volume>
                <fpage>1315</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15115768</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.dichgans.2005.371">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dichgans</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freilinger</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eckstein</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Babini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lorenz-Depiereux</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biskup</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrari</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herzog</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Maagdenberg</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pusch</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strom</surname>
                    <given-names>TM</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine.</article-title>
                <source>Lancet</source>
                <volume>366</volume>
                <fpage>371</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16054936</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.dravet.2002">
              <mixed-citation publication-type="book">Dravet C, Bureau M, Oguni H, Fukuyama Y, Cokar O. Severe myoclonic epilepsy in infancy. In: Roger J, Bureau M, Dravet C, Genton P, Tassinari CA, Wolf P, eds. <italic toggle="yes">Epileptic Syndromes in Infancy, Childhood and Adolescence</italic>. 3 ed. Eastleigh, UK: John Libbey; 2002:81-103.</mixed-citation>
            </ref>
            <ref id="gefs.REF.dressler.2010.404">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dressler</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>St&#x000f6;cklin</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reithofer</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benninger</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freilinger</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hauser</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reiter-Fink</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seidl</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trimmel-Schwahofer</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feucht</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Long-term outcome and tolerability of the ketogenic diet in drug-resistant childhood epilepsy--the Austrian experience.</article-title>
                <source>Seizure.</source>
                <volume>19</volume>
                <fpage>404</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">20598586</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.ebach.2005.210">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ebach</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joos</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doose</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stephani</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kurlemann</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fiedler</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hahn</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hauser</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hundt</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holthausen</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muller</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neubauer</surname>
                    <given-names>BA</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>SCN1A mutation analysis in myoclonic astatic epilepsy and severe idiopathic generalized epilepsy of infancy with generalized tonic-clonic seizures.</article-title>
                <source>Neuropediatrics</source>
                <volume>36</volume>
                <fpage>210</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">15944908</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.escayg.2010.1650">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Escayg</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldin</surname>
                    <given-names>AL</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Sodium channel SCN1A and epilepsy: mutations and mechanisms.</article-title>
                <source>Epilepsia.</source>
                <volume>51</volume>
                <fpage>1650</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">20831750</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.escayg.2001.866">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Escayg</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heils</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacDonald</surname>
                    <given-names>BT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haug</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sander</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meisler</surname>
                    <given-names>MH</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>A novel SCN1A mutation associated with generalized epilepsy with febrile seizures plus--and prevalence of variants in patients with epilepsy.</article-title>
                <source>Am J Hum Genet</source>
                <volume>68</volume>
                <fpage>866</fpage>
                <lpage>73</lpage>
                <pub-id pub-id-type="pmid">11254445</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.escayg.2000.343">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Escayg</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacDonald</surname>
                    <given-names>BT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meisler</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baulac</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huberfeld</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>An-Gourfinkel</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brice</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>LeGuern</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moulard</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chaigne</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buresi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malafosse</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2.</article-title>
                <source>Nat Genet</source>
                <volume>24</volume>
                <fpage>343</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">10742094</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.fujiwara.2006.s223">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fujiwara</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Clinical spectrum of mutations in SCN1A gene: severe myoclonic epilepsy in infancy and related epilepsies.</article-title>
                <source>Epilepsy Res.</source>
                <volume>70</volume>
                <supplement>Suppl 1</supplement>
                <fpage>S223</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">16806826</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.fujiwara.2003.531">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fujiwara</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sugawara</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mazaki-Miyazaki</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fukushima</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watanabe</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hara</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morikawa</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yagi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamakawa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inoue</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Mutations of sodium channel alpha subunit type 1 (SCN1A) in intractable childhood epilepsies with frequent generalized tonic-clonic seizures.</article-title>
                <source>Brain</source>
                <volume>126</volume>
                <fpage>531</fpage>
                <lpage>46</lpage>
                <pub-id pub-id-type="pmid">12566275</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.fukuma.2004.140">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fukuma</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oguni</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shirasaka</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watanabe</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyajima</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yasumoto</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohfu</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inoue</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watanachai</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kira</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsuo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muranaka</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sofue</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaneko</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitsudome</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirose</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Mutations of neuronal voltage-gated Na+ channel alpha 1 subunit gene SCN1A in core severe myoclonic epilepsy in infancy (SMEI) and in borderline SMEI (SMEB).</article-title>
                <source>Epilepsia</source>
                <volume>45</volume>
                <fpage>140</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">14738421</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.gaily.2013.1577">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gaily</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anttonen</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valanne</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liukkonen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tr&#x000e4;skelin</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Polvi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lommi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muona</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eriksson</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehesjoki</surname>
                    <given-names>AE</given-names>
                  </name>
                </person-group>
                <article-title>Dravet syndrome: new potential genetic modifiers, imaging abnormalities, and ictal findings.</article-title>
                <source>Epilepsia.</source>
                <year>2013</year>
                <volume>54</volume>
                <fpage>1577</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">23808377</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.gennaro.2006.489">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gennaro</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santorelli</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buti</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaggero</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gobbi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lini</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Granata</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freri</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parmeggiani</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Striano</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Veggiotti</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cardinali</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bricarelli</surname>
                    <given-names>FD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minetti</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zara</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Somatic and germline mosaicisms in severe myoclonic epilepsy of infancy.</article-title>
                <source>Biochem Biophys Res Commun</source>
                <volume>341</volume>
                <fpage>489</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">16430863</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.gennaro.2003.21">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gennaro</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Veggiotti</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malacarne</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Madia</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cecconi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cardinali</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cassetti</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cecconi</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bianchi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gobbi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zara</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Familial severe myoclonic epilepsy of infancy: truncation of Nav1.1 and genetic heterogeneity.</article-title>
                <source>Epileptic Disord</source>
                <volume>5</volume>
                <fpage>21</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">12773292</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.grosso.2007.609">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Grosso</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orrico</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Galli</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Bartolo</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sorrentino</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balestri</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>SCN1A mutation associated with atypical Panayiotopoulos syndrome.</article-title>
                <source>Neurology</source>
                <volume>69</volume>
                <fpage>609</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">17679682</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.guerrini.1998.508">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Guerrini</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dravet</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Genton</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Belmonte</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaminska</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dulac</surname>
                    <given-names>O</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Lamotrigine and seizure aggravation in severe myoclonic epilepsy.</article-title>
                <source>Epilepsia</source>
                <volume>39</volume>
                <fpage>508</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">9596203</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.harkin.2007.843">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Harkin</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McMahon</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iona</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dibbens</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pelekanos</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zuberi</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadleir</surname>
                    <given-names>LG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gill</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrell</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Connolly</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stanley</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harbord</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Batish</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seltzer</surname>
                    <given-names>WK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gardner</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sutherland</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulley</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>IE</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>The spectrum of SCN1A-related infantile epileptic encephalopathies.</article-title>
                <source>Brain</source>
                <volume>130</volume>
                <fpage>843</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">17347258</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.heron.2010.137">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Heron</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>IE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iona</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zuberi</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Birch</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McMahon</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruce</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulley</surname>
                    <given-names>JC</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>De novo SCN1A mutations in Dravet syndrome and related epileptic encephalopathies are largely of paternal origin.</article-title>
                <source>J Med Genet.</source>
                <volume>47</volume>
                <fpage>137</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">19589774</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.horn.1986.340">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Horn</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ater</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hurst</surname>
                    <given-names>DL</given-names>
                  </name>
                </person-group>
                <year>1986</year>
                <article-title>Carbamazepine-exacerbated epilepsy in children and adolescents.</article-title>
                <source>Pediatr Neurol</source>
                <volume>2</volume>
                <fpage>340</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">3508708</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.iannetti.2009.89">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Iannetti</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parisi</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spalice</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruggieri</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zara</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Addition of verapamil in the treatment of severe myoclonic epilepsy in infancy.</article-title>
                <source>Epilepsy Res.</source>
                <volume>85</volume>
                <fpage>89</fpage>
                <lpage>95</lpage>
                <pub-id pub-id-type="pmid">19303743</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.kanai.2004.329">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kanai</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirose</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oguni</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fukuma</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shirasaka</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyajima</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wada</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iwasa</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yasumoto</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsuo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ito</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitsudome</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaneko</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Effect of localization of missense mutations in SCN1A on epilepsy phenotype severity.</article-title>
                <source>Neurology.</source>
                <year>2004</year>
                <volume>63</volume>
                <fpage>329</fpage>
                <lpage>34</lpage>
                <pub-id pub-id-type="pmid">15277629</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.kimura.2005.424">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kimura</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sugawara</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mazaki-Miyazaki</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoshino</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nomura</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tateno</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hachimori</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamakawa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Segawa</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>A missense mutation in SCN1A in brothers with severe myoclonic epilepsy in infancy (SMEI) inherited from a father with febrile seizures.</article-title>
                <source>Brain Dev</source>
                <volume>27</volume>
                <fpage>424</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">16122630</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.krepischi.2010.2457">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Krepischi</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Knijnenburg</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertola</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pearson</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bijlsma</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Szuhai</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kok</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vianna-Morgante</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenberg</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Two distinct regions in 2q24.2-q24.3 associated with idiopathic epilepsy.</article-title>
                <source>Epilepsia.</source>
                <volume>51</volume>
                <fpage>2457</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">21204806</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.liao.2010.1454">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Liao</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anttonen</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liukkonen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaily</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maljevic</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schubert</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bellan-Koch</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petrou</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahonen</surname>
                    <given-names>VE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lerche</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehesjoki</surname>
                    <given-names>AE</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>SCN2A mutation associated with neonatal epilepsy, late-onset episodic ataxia, myoclonus, and pain.</article-title>
                <source>Neurology.</source>
                <volume>75</volume>
                <fpage>1454</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">20956790</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.livingston.2009.503">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Livingston</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cross</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mclellan</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Birch</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zuberi</surname>
                    <given-names>SM</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>A novel inherited mutation in the voltage sensor region of SCN1A is associated with Panayiotopoulos syndrome in siblings and generalized epilepsy with febrile seizures plus.</article-title>
                <source>J Child Neurol.</source>
                <volume>24</volume>
                <fpage>503</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">19339291</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.madia.2006.1230">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Madia</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Striano</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gennaro</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malacarne</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paravidino</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biancheri</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Budetta</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cilio</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaggero</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pierluigi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minetti</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zara</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Cryptic chromosome deletions involving SCN1A in severe myoclonic epilepsy of infancy.</article-title>
                <source>Neurology</source>
                <volume>67</volume>
                <fpage>1230</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">17030758</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.malow.2000.1002">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Malow</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levy</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maturen</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bowes</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Obstructive sleep apnea is common in medically refractory epilepsy patients.</article-title>
                <source>Neurology.</source>
                <volume>55</volume>
                <fpage>1002</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">11061259</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.mantegazza.2005.18177">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mantegazza</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gambardella</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rusconi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiavon</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Annesi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cassulini</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Labate</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carrideo</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chifari</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Canevini</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Canger</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Franceschetti</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Annesi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wanke</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quattrone</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Identification of an Nav1.1 sodium channel (SCN1A) loss-of-function mutation associated with familial simple febrile seizures.</article-title>
                <source>Proc Natl Acad Sci U S A</source>
                <volume>102</volume>
                <fpage>18177</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">16326807</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.marini.2010.646">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Marini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mei</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parmeggiani</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Norci</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calado</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrari</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moreira</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pisano</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Specchio</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vigevano</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Battaglia</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guerrini</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Protocadherin 19 mutations in girls with infantile-onset epilepsy.</article-title>
                <source>Neurology.</source>
                <volume>75</volume>
                <fpage>646</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">20713952</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.marini.2007.1678">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Marini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mei</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Temudo</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrari</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buti</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dravet</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dias</surname>
                    <given-names>AI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moreira</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calado</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seri</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neville</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Narbona</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reid</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michelucci</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sicca</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cross</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guerrini</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Idiopathic epilepsies with seizures precipitated by fever and SCN1A abnormalities.</article-title>
                <source>Epilepsia.</source>
                <volume>48</volume>
                <fpage>1678</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">17561957</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.marini.2009.1670">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Marini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>IE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nabbout</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mei</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cox</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dibbens</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McMahon</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iona</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carpintero</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elia</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cilio</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Specchio</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giordano</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Striano</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gennaro</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cross</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kivity</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neufeld</surname>
                    <given-names>MY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Afawi</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keene</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dulac</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zara</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guerrini</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulley</surname>
                    <given-names>JC</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>SCN1A duplications and deletions detected in Dravet syndrome: implications for molecular diagnosis.</article-title>
                <source>Epilepsia.</source>
                <volume>50</volume>
                <fpage>1670</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">19400878</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.mcintosh.2010.592">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>McIntosh</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McMahon</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dibbens</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iona</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulley</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>IE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Effects of vaccination on onset and outcome of Dravet syndrome: a retrospective study.</article-title>
                <source>Lancet Neurol.</source>
                <volume>9</volume>
                <fpage>592</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">20447868</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.meador.2009.1597">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Meador</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baker</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Browning</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clayton-Smith</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Combs-Cantrell</surname>
                    <given-names>DT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalayjian</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kanner</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liporace</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pennell</surname>
                    <given-names>PB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Privitera</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loring</surname>
                    <given-names>DW</given-names>
                  </name>
                  <collab>NEAD Study Group</collab>
                </person-group>
                <year>2009</year>
                <article-title>Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs.</article-title>
                <source>N Engl J Med.</source>
                <volume>360</volume>
                <fpage>1597</fpage>
                <lpage>605</lpage>
                <pub-id pub-id-type="pmid">19369666</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.mulley.2006.1094">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mulley</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nelson</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guerrero</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dibbens</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iona</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McMahon</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harkin</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schouten</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>IE</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>A new molecular mechanism for severe myoclonic epilepsy of infancy: exonic deletions in SCN1A.</article-title>
                <source>Neurology</source>
                <volume>67</volume>
                <fpage>1094</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">17000989</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.mulley.2005.535">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mulley</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>IE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petrou</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dibbens</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harkin</surname>
                    <given-names>LA</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>SCN1A mutations and epilepsy.</article-title>
                <source>Hum Mutat</source>
                <volume>25</volume>
                <fpage>535</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">15880351</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.mulley.2013.e122">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mulley</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hodgson</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McMahon</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iona</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bellows</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mullen</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrell</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mackay</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadleir</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bleasel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gill</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Webster</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wirrell</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harbord</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sisodiya</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kivity</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>IE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dibbens</surname>
                    <given-names>LM</given-names>
                  </name>
                </person-group>
                <article-title>Role of the sodium channel SCN9A in genetic epilepsy with febrile seizures plus and Dravet syndrome.</article-title>
                <source>Epilepsia.</source>
                <year>2013</year>
                <volume>54</volume>
                <fpage>e122</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">23895530</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.nabbout.2011.e54">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nabbout</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Copioli</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chipaux</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chemaly</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Desguerre</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dulac</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chiron</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Ketogenic diet also benefits Dravet syndrome patients receiving stiripentol: a prospective pilot study.</article-title>
                <source>Epilepsia.</source>
                <volume>52</volume>
                <fpage>e54</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">21569025</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.nabbout.2003.1961">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nabbout</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gennaro</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dalla Bernardina</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dulac</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Madia</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Capovilla</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chiron</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cristofori</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elia</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fontana</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaggero</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Granata</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guerrini</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>La Selva</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lispi</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matricardi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romeo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tzolas</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valseriati</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Veggiotti</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vigevano</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vallee</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dagna Bricarelli</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bianchi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zara</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Spectrum of SCN1A mutations in severe myoclonic epilepsy of infancy.</article-title>
                <source>Neurology</source>
                <volume>60</volume>
                <fpage>1961</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">12821740</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.nakayama.2006.s190">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nakayama</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arinami</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Molecular genetics of febrile seizures.</article-title>
                <source>Epilepsy Res</source>
                <volume>70</volume>
                <fpage>S190</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16887333</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.nicolai.2008.92">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nicolai</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gunning</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leroy</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ceulemans</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vles</surname>
                    <given-names>JS</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Acute hepatic injury in four children with Dravet syndrome: valproic acid, topiramate or acetaminophen?</article-title>
                <source>Seizure.</source>
                <volume>17</volume>
                <fpage>92</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">17697789</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.nikanorova.2011">
              <mixed-citation publication-type="book">Nikanorova M, Genton P, Johannessen SI, Johannessen Landmark C. Stiripentol. In Nikanorova M, Genton P, Johannessen SI, Johannessen Landmark C. <italic toggle="yes">Topics in Epilepsy Volume 4: Orphan Drugs in Epilepsy.</italic> Esher, UK: John Libbey Eurotext; 2011:39-47.</mixed-citation>
            </ref>
            <ref id="gefs.REF.nolan.2008.690">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nolan</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Camfield</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Camfield</surname>
                    <given-names>PR</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Coping with a child with Dravet syndrome: insights from families.</article-title>
                <source>J Child Neurol.</source>
                <volume>23</volume>
                <fpage>690</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">18344453</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.ohmori.2008a.521">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ohmori</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ouchida</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kobayashi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jitsumori</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inoue</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsui</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohtsuka</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maegaki</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <year>2008a</year>
                <article-title>Rasmussen encephalitis associated with SCN 1 A mutation.</article-title>
                <source>Epilepsia.</source>
                <volume>49</volume>
                <fpage>521</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">18031552</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.ohmori.2013.209">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ohmori</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ouchida</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kobayashi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jitsumori</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mori</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michiue</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishiki</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohtsuka</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsui</surname>
                    <given-names>H.</given-names>
                  </name>
                </person-group>
                <article-title>CACNA1A variants may modify the epileptic phenotype of Dravet syndrome.</article-title>
                <source>Neurobiol Dis.</source>
                <year>2013</year>
                <volume>50</volume>
                <fpage>209</fpage>
                <lpage>17</lpage>
                <pub-id pub-id-type="pmid">23103419</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.ohmori.2008b.349">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ohmori</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ouchida</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miki</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mimaki</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kiyonaka</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishiki</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tomizawa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mori</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsui</surname>
                    <given-names>H. A</given-names>
                  </name>
                </person-group>
                <article-title>CACNB4 mutation shows that altered Ca(v)2.1 function may be a genetic modifier of severe myoclonic epilepsy in infancy.</article-title>
                <source>Neurobiol Dis.</source>
                <year>2008b</year>
                <volume>32</volume>
                <fpage>349</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">18755274</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.pal.2010.445">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pal</surname>
                    <given-names>DK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pong</surname>
                    <given-names>AW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chung</surname>
                    <given-names>WK</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Genetic evaluation and counseling for epilepsy.</article-title>
                <source>Nat Rev Neurol.</source>
                <volume>6</volume>
                <fpage>445</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">20647993</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.patino.2009.10764">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Patino</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Claes</surname>
                    <given-names>LR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopez-Santiago</surname>
                    <given-names>LF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slat</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dondeti</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Malley</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gray</surname>
                    <given-names>CB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyazaki</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nukina</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oyama</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Jonghe</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Isom</surname>
                    <given-names>LL</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>A functional null mutation of SCN1B in a patient with Dravet syndrome.</article-title>
                <source>J Neurosci.</source>
                <volume>29</volume>
                <fpage>10764</fpage>
                <lpage>78</lpage>
                <pub-id pub-id-type="pmid">19710327</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.pereira.2004.191">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pereira</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vieira</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barroca</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roll</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carvalhas</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cau</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sequeira</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Genton</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Szepetowski</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Severe epilepsy, retardation, and dysmorphic features with a 2q deletion including SCN1A and SCN2A.</article-title>
                <source>Neurology</source>
                <volume>63</volume>
                <fpage>191</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">15249644</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.quilichini.2006.704">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Quilichini</surname>
                    <given-names>PP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chiron</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ben-Ari</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gozlan</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Stiripentol, a putative antiepileptic drug, enhances the duration of opening of GABA-A receptor channels.</article-title>
                <source>Epilepsia</source>
                <volume>47</volume>
                <fpage>704</fpage>
                <lpage>16</lpage>
                <pub-id pub-id-type="pmid">16650136</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.ragona.2011.386">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ragona</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Granata</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dalla Bernardina</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Offredi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Darra</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Battaglia</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morbi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brazzo</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cappelletti</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chieffo</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Giorgi</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fontana</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freri</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toraldo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Specchio</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Veggiotti</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vigevano</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guerrini</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guzzetta</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dravet</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Cognitive development in Dravet syndrome: a retrospective, multicenter study of 26 patients.</article-title>
                <source>Epilepsia.</source>
                <volume>52</volume>
                <fpage>386</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">21269283</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.rieder.2010.598">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rieder</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chauhan</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singh</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagarkatti</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagarkatti</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression.</article-title>
                <source>Immunobiology.</source>
                <year>2010</year>
                <volume>215</volume>
                <fpage>598</fpage>
                <lpage>605</lpage>
                <pub-id pub-id-type="pmid">19457575</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.rilstone.2012.1421">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rilstone</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coelho</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minassian</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrade</surname>
                    <given-names>DM</given-names>
                  </name>
                </person-group>
                <article-title>Dravet syndrome: seizure control and gait in adults with different SCN1A mutations.</article-title>
                <source>Epilepsia.</source>
                <year>2012</year>
                <volume>53</volume>
                <fpage>1421</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">22780858</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.riva.2009.2339">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Riva</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vago</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pantaleoni</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bulgheroni</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mantegazza</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Franceschetti</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Progressive neurocognitive decline in two children with Dravet syndrome, de novo SCN1A truncations and different epileptic phenotypes.</article-title>
                <source>Am J Med Genet A.</source>
                <volume>149A</volume>
                <fpage>2339</fpage>
                <lpage>45</lpage>
                <pub-id pub-id-type="pmid">19764027</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.rodda.2012.873">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rodda</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>IE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McMahon</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graham</surname>
                    <given-names>HK</given-names>
                  </name>
                </person-group>
                <article-title>Progressive gait deterioration in adolescents with Dravet syndrome.</article-title>
                <source>Arch Neurol.</source>
                <year>2012</year>
                <volume>69</volume>
                <fpage>873</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">22409937</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.roger.2006">
              <mixed-citation publication-type="book">Roger J, Bureau M, Dravet C, Genton P, Tassinari CA, Wolf P. <italic toggle="yes">Epileptic Syndromes in Infancy, Childhood and Adolescence</italic>. 3 ed. Eastleigh, UK: John Libbey; 2006.</mixed-citation>
            </ref>
            <ref id="gefs.REF.saito.2001.231">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Saito</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oguni</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Awaya</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayashi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osawa</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Phenytoin-induced choreoathetosis in patients with severe myoclonic epilepsy in infancy.</article-title>
                <source>Neuropediatrics</source>
                <volume>32</volume>
                <fpage>231</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">11748493</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.samr_n.1997.981">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Samr&#x000e9;n</surname>
                    <given-names>EB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Duijn</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koch</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hiilesmaa</surname>
                    <given-names>VK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klepel</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bardy</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mannagetta</surname>
                    <given-names>GB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deichl</surname>
                    <given-names>AW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaily</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Granstr&#x000f6;m</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meinardi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grobbee</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hofman</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Janz</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindhout</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy.</article-title>
                <source>Epilepsia.</source>
                <volume>38</volume>
                <fpage>981</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">9579936</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.scheffer.1997.479">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>IE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Generalized epilepsy with febrile seizures plus. A genetic disorder with heterogeneous clinical phenotypes.</article-title>
                <source>Brain</source>
                <volume>120</volume>
                <fpage>479</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">9126059</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.scheffer.2007.100">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>IE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harkin</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grinton</surname>
                    <given-names>BE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dibbens</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turner</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zielinski</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xu</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jackson</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adams</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Connellan</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petrou</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wellard</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Briellmann</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wallace</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulley</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Temporal lobe epilepsy and GEFS+ phenotypes associated with SCN1B mutations.</article-title>
                <source>Brain.</source>
                <volume>130</volume>
                <fpage>100</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">17020904</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.selmer.2009.555">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Selmer</surname>
                    <given-names>KK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lund</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brandal</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Undlien</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brodtkorb</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>SCN1A mutation screening in adult patients with Lennox-Gastaut syndrome features.</article-title>
                <source>Epilepsy Behav.</source>
                <volume>16</volume>
                <fpage>555</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">19782004</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.shi.2010.375">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shi</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishii</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshida</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okada</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morita</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagafuji</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yasumoto</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaneko</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kojima</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirose</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Mutational analysis of GABRG2 in a Japanese cohort with childhood epilepsies.</article-title>
                <source>J Hum Genet.</source>
                <volume>55</volume>
                <fpage>375</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">20485450</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.shi.2009.758">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shi</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yasumoto</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakagawa</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fukasawa</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uchiya</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirose</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Missense mutation of the sodium channel gene SCN2A causes Dravet syndrome.</article-title>
                <source>Brain Dev.</source>
                <volume>31</volume>
                <fpage>758</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">19783390</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.sijben.2009.953">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sijben</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sithinamsuwan</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Radhakrishnan</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Badawy</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dibbens</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mazarib</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lev</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lerman-Sagie</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Straussberg</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>IE</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Does a SCN1A gene mutation confer earlier age of onset of febrile seizures in GEFS+?</article-title>
                <source>Epilepsia.</source>
                <volume>50</volume>
                <fpage>953</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">19292758</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.singh.2009.e1000649">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Singh</surname>
                    <given-names>NA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pappas</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dahle</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Claes</surname>
                    <given-names>LR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pruess</surname>
                    <given-names>TH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Jonghe</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thompson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dixon</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gurnett</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peiffer</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>White</surname>
                    <given-names>HS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Filloux</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leppert</surname>
                    <given-names>MF</given-names>
                  </name>
                </person-group>
                <article-title>A role of SCN9A in human epilepsies, as a cause of febrile seizures and as a potential modifier of Dravet syndrome.</article-title>
                <source>PLoS Genet.</source>
                <year>2009</year>
                <volume>5</volume>
                <fpage>e1000649</fpage>
                <pub-id pub-id-type="pmid">19763161</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.singh.2001.837">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Singh</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whitehouse</surname>
                    <given-names>WP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harvey</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keene</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seni</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crossland</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>IE</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Severe myoclonic epilepsy of infancy: extended spectrum of GEFS+?</article-title>
                <source>Epilepsia</source>
                <volume>42</volume>
                <fpage>837</fpage>
                <lpage>44</lpage>
                <pub-id pub-id-type="pmid">11488881</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.striano.2007.1092">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Striano</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mancardi</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biancheri</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Madia</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gennaro</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paravidino</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beccaria</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Capovilla</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dalla Bernardina</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Darra</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elia</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giordano</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gobbi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Granata</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ragona</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guerrini</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mei</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Longaretti</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romeo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siri</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Specchio</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vigevano</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Striano</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tortora</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minetti</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dravet</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaggero</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zara</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Brain MRI findings in severe myoclonic epilepsy in infancy and genotype-phenotype correlations.</article-title>
                <source>Epilepsia.</source>
                <volume>48</volume>
                <fpage>1092</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">17381446</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.sugawara.2001.6384">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sugawara</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsurubuchi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Agarwala</surname>
                    <given-names>KL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ito</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fukuma</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mazaki-Miyazaki</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagafuji</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Noda</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Imoto</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wada</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitsudome</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaneko</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montal</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagata</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirose</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamakawa</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>A missense mutation of the Na+ channel alpha II subunit gene Na(v)1.2 in a patient with febrile and afebrile seizures causes channel dysfunction.</article-title>
                <source>Proc Natl Acad Sci U S A</source>
                <volume>98</volume>
                <fpage>6384</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">11371648</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.suls.2006.914">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Suls</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Claeys</surname>
                    <given-names>KG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goossens</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harding</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Luijk</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheers</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deprez</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Audenaert</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Dyck</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beeckmans</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smouts</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ceulemans</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lagae</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buyse</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barisic</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Misson</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wauters</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Del-Favero</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Jonghe</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Claes</surname>
                    <given-names>LR</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Microdeletions involving the SCN1A gene may be common in SCN1A-mutation-negative SMEI patients.</article-title>
                <source>Hum Mutat.</source>
                <volume>27</volume>
                <fpage>914</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">16865694</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.suls.2010.72">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Suls</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Velizarova</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yordanova</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deprez</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Dyck</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wauters</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guergueltcheva</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Claes</surname>
                    <given-names>LR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kremensky</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jordanova</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Jonghe</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Four generations of epilepsy caused by an inherited microdeletion of the SCN1A gene.</article-title>
                <source>Neurology.</source>
                <volume>75</volume>
                <fpage>72</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">20484682</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.takayanagi.2010.1886">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Takayanagi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haginoya</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Umehara</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kitamura</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Numata</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wakusawa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hino-Fukuyo</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mazaki</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamakawa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohura</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohtake</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Acute encephalopathy with a truncation mutation in the SCN1A gene: a case report.</article-title>
                <source>Epilepsia.</source>
                <volume>51</volume>
                <fpage>1886</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">20491869</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.tanabe.2008.629">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tanabe</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Awaya</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsuishi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iyoda</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagai</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kurihara</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamamoto</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minagawa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maekawa</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Management of and prophylaxis against status epilepticus in children with severe myoclonic epilepsy in infancy (SMEI; Dravet syndrome)--a nationwide questionnaire survey in Japan.</article-title>
                <source>Brain Dev.</source>
                <volume>30</volume>
                <fpage>629</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">18424028</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.thanh.2002.1120">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Thanh</surname>
                    <given-names>TN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chiron</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dellatolas</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rey</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pons</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vincent</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dulac</surname>
                    <given-names>O</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <comment>[Long-term efficacy and tolerance of stiripentaol in severe myoclonic epilepsy of infancy (Dravet's syndrome)]</comment>
                <source>Arch Pediatr</source>
                <volume>9</volume>
                <fpage>1120</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">12503502</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.trobaumann.2011.175">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tro-Baumann</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>von Spiczak</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lotte</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bast</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haberlandt</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sassen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freund</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leiz</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stephani</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boor</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holthausen</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Helbig</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kluger</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>A retrospective study of the relation between vaccination and occurrence of seizures in Dravet syndrome.</article-title>
                <source>Epilepsia.</source>
                <volume>52</volume>
                <fpage>175</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">21219303</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.wallace.2003.765">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wallace</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hodgson</surname>
                    <given-names>BL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grinton</surname>
                    <given-names>BE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gardiner</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodriguez-Casero</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadleir</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morgan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harkin</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dibbens</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamamoto</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulley</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>IE</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Sodium channel alpha1-subunit mutations in severe myoclonic epilepsy of infancy and infantile spasms.</article-title>
                <source>Neurology</source>
                <volume>61</volume>
                <fpage>765</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">14504318</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.wallace.2001a.49">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wallace</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petrou</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harkin</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bowser</surname>
                    <given-names>DN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Panchal</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sutherland</surname>
                    <given-names>GR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulley</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>IE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                </person-group>
                <year>2001a</year>
                <article-title>Mutant GABA(A) receptor gamma2-subunit in childhood absence epilepsy and febrile seizures.</article-title>
                <source>Nat Genet</source>
                <volume>28</volume>
                <fpage>49</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">11326275</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.wallace.2001b.859">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wallace</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>IE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barnett</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richards</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dibbens</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Desai</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lerman-Sagie</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lev</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mazarib</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brand</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ben-Zeev</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goikhman</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singh</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kremmidiotis</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gardner</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sutherland</surname>
                    <given-names>GR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>George</surname>
                    <given-names>AL</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Mulley</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                </person-group>
                <year>2001b</year>
                <article-title>Neuronal sodium-channel alpha1-subunit mutations in generalized epilepsy with febrile seizures plus.</article-title>
                <source>Am J Hum Genet</source>
                <volume>68</volume>
                <fpage>859</fpage>
                <lpage>65</lpage>
                <pub-id pub-id-type="pmid">11254444</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.wallace.2002.1426">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wallace</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>IE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parasivam</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barnett</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wallace</surname>
                    <given-names>GB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sutherland</surname>
                    <given-names>GR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulley</surname>
                    <given-names>JC</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Generalized epilepsy with febrile seizures plus: mutation of the sodium channel subunit SCN1B.</article-title>
                <source>Neurology</source>
                <volume>58</volume>
                <fpage>1426</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12011299</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.wallace.1998.366">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wallace</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singh</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>IE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>George</surname>
                    <given-names>AL</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Phillips</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saar</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reis</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>EW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sutherland</surname>
                    <given-names>GR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulley</surname>
                    <given-names>JC</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel beta1 subunit gene SCN1B.</article-title>
                <source>Nat Genet</source>
                <volume>19</volume>
                <fpage>366</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">9697698</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.weiss.2003.186">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Weiss</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Escayg</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kearney</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trudeau</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacDonald</surname>
                    <given-names>BT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mori</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reichert</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buxbaum</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meisler</surname>
                    <given-names>MH</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Sodium channels SCN1A, SCN2A and SCN3A in familial autism.</article-title>
                <source>Mol Psychiatry</source>
                <volume>8</volume>
                <fpage>186</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">12610651</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.wirrell.2013.1595">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wirrell</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laux</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Franz</surname>
                    <given-names>DN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sullivan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saneto</surname>
                    <given-names>RP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morse</surname>
                    <given-names>RP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devinsky</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chugani</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hernandez</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamiwka</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mikati</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valencia</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Guern</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chancharme</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Menezes</surname>
                    <given-names>MS</given-names>
                  </name>
                </person-group>
                <article-title>Stiripentol in Dravet syndrome: results of a retrospective U.S. study.</article-title>
                <source>Epilepsia.</source>
                <year>2013</year>
                <volume>54</volume>
                <fpage>1595</fpage>
                <lpage>604</lpage>
                <pub-id pub-id-type="pmid">23848835</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.yu.2006.1142">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yu</surname>
                    <given-names>FH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mantegazza</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Westenbroek</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robbins</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalume</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burton</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spain</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McKnight</surname>
                    <given-names>GS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheuer</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Catterall</surname>
                    <given-names>WA</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy.</article-title>
                <source>Nat Neurosci</source>
                <volume>9</volume>
                <fpage>1142</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">16921370</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.yu.2010.443">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yu</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shi</surname>
                    <given-names>YW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gao</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deng</surname>
                    <given-names>WY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>XR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Long</surname>
                    <given-names>YS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yi</surname>
                    <given-names>YH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liao</surname>
                    <given-names>WP</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Milder phenotype with SCN1A truncation mutation other than SMEI.</article-title>
                <source>Seizure.</source>
                <volume>19</volume>
                <fpage>443</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">20630778</pub-id>
              </element-citation>
            </ref>
            <ref id="gefs.REF.zuberi.2011.594">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zuberi</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunklaus</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Birch</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reavey</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duncan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forbes</surname>
                    <given-names>GH</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Genotype-phenotype associations in SCN1A-related epilepsies.</article-title>
                <source>Neurology.</source>
                <volume>76</volume>
                <fpage>594</fpage>
                <lpage>600</lpage>
                <pub-id pub-id-type="pmid">21248271</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="gefs.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="gefs.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>15 May 2014 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>10 November 2011 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>29 November 2007 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>13 October 2006 (msm) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="gefs.F1" orientation="portrait">
          <label>Figure 1. </label>
          <caption>
            <p>Findings in a family illustrating variable expressivity among individuals with the same pathogenic variant. The proband, a boy (arrow) with febrile convulsions since age seven months, had frequent, difficult-to-control partial seizures beginning at age three years. His sister had infrequent partial seizures starting early in school age. Their father had a single seizure as a young adult. All three had the same pathogenic variant in the fourth domain fifth segment (D4S5) on the pore region of the SCN1A (Na<sub>v</sub>1.1) protein (see <xref ref-type="sec" rid="gefs.Molecular_Genetic_Pathogenesis">Molecular Genetic Pathogenesis</xref>) [M Sotero, personal observation].</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="gefs-Image001" position="anchor" orientation="portrait"/>
        </fig>
        <fig position="float" id="gefs.F2" orientation="portrait">
          <label>Figure 2. </label>
          <caption>
            <p>Topologic diagram of Na<sub>v</sub>1.1, the alpha subunit of the neuronal voltage-gated sodium channel encoded by <italic toggle="yes">SCN1A</italic>. Na<sub>v</sub>1.1 is 2,000 amino acids in size and has four homologous domains (D1-D4) that fold around a central pore and are connected by cytoplasmic loops. Each domain has six transmembrane segments, S1-S6. The cytoplasmic loop between the third and fourth domain forms the inactivation gate, while the S4 segments make up the voltage sensor. The pore is formed by parts of S5, S6, and the P-loop between them. Voltage-gated sodium channels have one or more modulatory beta subunits (230 amino acids each, not pictured) that consist of a single transmembrane segment, an extracellular IgG loop, and a short intracellular C-terminus. All voltage-gated sodium channels (Na<sub>v</sub>1.1 - 1.9) have structural homology [<xref ref-type="bibr" rid="gefs.REF.catterall.2000.13">Catterall 2000</xref>].</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="gefs-Image002" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
